US20100297743A1 - Coenzyme-binding glucose dehydrogenase - Google Patents

Coenzyme-binding glucose dehydrogenase Download PDF

Info

Publication number
US20100297743A1
US20100297743A1 US12/851,668 US85166810A US2010297743A1 US 20100297743 A1 US20100297743 A1 US 20100297743A1 US 85166810 A US85166810 A US 85166810A US 2010297743 A1 US2010297743 A1 US 2010297743A1
Authority
US
United States
Prior art keywords
genus
coenzyme
glucose dehydrogenase
binding glucose
glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US12/851,668
Inventor
Hironori Omura
Hirokazu Sanada
Takako Yada
Tetsunari Morita
Mika Kuyama
Tokuji Ikeda
Kenji Kano
Seiya Tsujimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PHC Corp
Original Assignee
Hironori Omura
Hirokazu Sanada
Takako Yada
Tetsunari Morita
Mika Kuyama
Tokuji Ikeda
Kenji Kano
Seiya Tsujimura
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hironori Omura, Hirokazu Sanada, Takako Yada, Tetsunari Morita, Mika Kuyama, Tokuji Ikeda, Kenji Kano, Seiya Tsujimura filed Critical Hironori Omura
Priority to US12/851,668 priority Critical patent/US20100297743A1/en
Publication of US20100297743A1 publication Critical patent/US20100297743A1/en
Assigned to PHC CORPORATION reassignment PHC CORPORATION ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: IKEDA FOOD RESEARCH CO., LTD.
Priority to US16/278,025 priority patent/US11345897B2/en
Priority to US16/278,008 priority patent/US10988738B2/en
Priority to US16/278,019 priority patent/US11225645B2/en
Priority to US16/278,030 priority patent/US11155789B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/26Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
    • C12Q1/32Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose

Definitions

  • the present invention relates to a novel soluble coenzyme-binding glucose dehydrogenase, a method for producing the coenzyme-binding glucose dehydrogenase, and a microorganism having an ability of producing the coenzyme-binding glucose dehydrogenase.
  • the invention also relates to a method for measuring glucose in a sample employing the coenzyme-binding glucose dehydrogenase, and a reagent and a reagent composition containing the coenzyme-binding glucose dehydrogenase. Moreover, the invention relates to utilization in producing and analyzing a material such as a starting material, including a method for producing an organic compound.
  • the invention further relates to a biosensor capable of rapidly and conveniently quantifying a particular component in a sample at a high accuracy.
  • the invention relates to a glucose sensor employing the coenzyme-binding glucose dehydrogenase.
  • Glucose is present in blood and utilized as an important marker for diabetes.
  • a method for measuring a glucose has conventionally been a chemical method or an enzymatic method, and an enzymatic method is regarded generally to be excellent in view of the specificity and the safety.
  • Such an enzymatic method is, for example, be a measurement using a glucose oxidase, glucose-6-phosphate dehydrogenase or an NAD(P)-dependent glucose dehydrogenase.
  • the methods employing the glucose oxidase and the glucose-6-phosphate dehydrogenase are not convenient reaction systems since they employ a plural of enzymes.
  • the methods employing the glucose-6-phosphate dehydrogenase and the NAD(P)-dependent glucose dehydrogenase pose a complication due to the requirement of adding a coenzyme NAD(P) to the reaction systems.
  • biosensors were proposed as modes for quantifying a particular component in a sample conveniently without diluting or stirring a sample solution.
  • a biosensor was proposed in which an electrode system consisting of an action electrode, a counter electrode and a reference electrode was formed by a screen printing on an insulating board. This electrode system and the like was in contact with an enzymatic reaction layer formed thereon containing a hydrophilic polymer, a redox enzyme and an electron acceptor.
  • the number of diabetes patient is increasing year by year, and a method for measuring a blood sugar and a means for controlling the blood sugar level are desired which can be utilized not only in a hospital but also at home and which is convenient. While a simple glucose sensor is employed currently for measuring the blood sugar, it frequently employs a glucose oxidase which is highly suspected to give a measured value involving an error due to a level of the residual oxygen.
  • a biosensor employing a glucose dehydrogenase which is dependent on a nicotinamide-based coenzyme exhibits a high background noise and involves a complicated reaction system due to the requirement of adding a coenzyme or an auxiliary enzyme separately, and it also suffers from a disadvantage due to the requirement of an expensive optical system upon measuring a chromogenic system.
  • a glucose dehydrogenase whose coenzyme is the pyrroloquinolinequinone derived from Escherichia coli JP-A-10-243786
  • a glucose dehydrogenase whose coenzyme is the pyrroloquinolinequinone derived from Pseudomonas sp. Agric. Biol. Chem. (1980) 44:1505-1512
  • a glucose dehydrogenase whose coenzyme is the pyrroloquinolinequinone derived from Gluconobacter suboxydans (Agric. Biol. Chem.
  • an objective of the invention is to provide a novel glucose dehydrogenase which exhibits an excellent substrate-recognizing ability toward glucose and which has low activity on maltose, and also to provide a method for producing the same and a microorganism having an ability of producing the same.
  • Another objective of the invention is to provide excellent glucose measuring method, measuring reagent and biosensor which employ the novel glucose dehydrogenase and which are capable of quantifying glucose rapidly and conveniently at a high accuracy, as well as a glucose-eliminating reagent.
  • the invention is accomplished for solving the problems mentioned above, and the inventors made an effort in various ways and then focused on a novel soluble coenzyme-binding glucose dehydrogenase.
  • the coenzyme-binding glucose dehydrogenase catalyzes a glucose-oxidizing reaction in the presence of an electron acceptor, and is classified for example as EC (Enzyme Code) 1.1.99.
  • the inventors also made an effort in characterizing various microorganisms producing the coenzyme-binding glucose dehydrogenase, and finally discovered a coenzyme-binding glucose dehydrogenase-producing microorganism and a coenzyme-binding glucose dehydrogenase.
  • the invention provides a glucose dehydrogenase to which a coenzyme is bound continuously upon a catalytic reaction.
  • the coenzyme-binding glucose dehydrogenase has a physicochemical ability of catalyzing a reaction for oxidizing glucose, especially a hydroxyl group in the 1st-position of glucose, in the presence of an electron acceptor.
  • the coenzyme-binding glucose dehydrogenase has 5% or less activity to maltose, preferably 3% or less; thus it has a poor activity on the maltose.
  • the coenzyme-binding glucose dehydrogenase allows its enzymatic activity to be inhibited characteristically by 50% or more at 5 mM of 1,10-phenanthroline, preferably by 50% or more at 2 mM as a final concentration of 1,10-phenanthroline, more preferably by 50% or more at 1 mM of 1,10-phenanthroline.
  • the coenzyme-binding glucose dehydrogenase preserves its residual enzymatic activity at a level as high as 85% or more even after a heat treatment for 15 minutes at 50° C. in the presence of 50 mM sodium citrate buffer solution (pH5.5).
  • the coenzyme which is bound to the inventive glucose dehydrogenase may for example be a flavin compound, including a coenzyme such as flavin adenine dinucleotide.
  • the invention also includes, with respect to a protein having the characteristics of those of the coenzyme-binding glucose dehydrogenase and/or characteristics equivalent substantially thereto as well as its salt, a protein which has an amino acid sequence encoding the protein or an amino acid sequence containing a mutation resulting from a deletion, substitution or addition of one or more amino acid residues in the sequence and which is biologically active and stable.
  • the inventive coenzyme-binding glucose dehydrogenase is a microorganism-derived coenzyme-binding glucose dehydrogenase, preferably a eukaryotic microorganism-derived coenzyme-binding glucose dehydrogenase, more preferably the deposited strain FERM BP-08578-derived coenzyme-binding glucose dehydrogenase.
  • the coenzyme-binding glucose dehydrogenase discovered in this invention is characterized by its higher stability when compared with that of the known Aspergillus oryzae -derived coenzyme-binding glucose dehydrogenase, and also by a favorably convenient handling for quenching because of its ability of being inhibited by a trace amount of 1,10-phenanthroline in addition to a heavy metal ion.
  • the invention provides a method for producing the novel soluble coenzyme-binding glucose dehydrogenase.
  • the invention provides a microorganism having an ability of producing the novel soluble coenzyme-binding glucose dehydrogenase.
  • the microorganism is preferably a eukaryotic microorganism, more preferably, genus Aspergillus , further preferably, Aspergillus terreus , and most preferably, the deposited strain FERM BP-08578.
  • the invention provides a method using the novel soluble coenzyme-binding glucose dehydrogenase.
  • a method for measuring glucose using the coenzyme-binding glucose dehydrogenase is provided for measuring glucose in a sample.
  • a method for eliminating glucose using the coenzyme-binding glucose dehydrogenase and a method for producing an organic compound are also provided.
  • the invention provides a reagent containing the novel soluble coenzyme-binding glucose dehydrogenase.
  • the reagent is preferably a glucose-measuring reagent containing the coenzyme-binding glucose dehydrogenase employed for measuring the glucose in a sample, and a glucose-eliminating reagent containing the coenzyme-binding glucose dehydrogenase as well as an organic compound-producing reagent.
  • the invention provides a reagent composition containing the novel soluble coenzyme-binding glucose dehydrogenase.
  • the composition is preferably a glucose-measuring composition containing the coenzyme-binding glucose dehydrogenase employed for measuring glucose in a sample, and a glucose-eliminating composition containing the coenzyme-binding glucose dehydrogenase as well as an organic compound-producing composition.
  • the invention provides a biosensor employing the novel soluble coenzyme-binding glucose dehydrogenase and a biosensor capable of quantifying and/or qualifying a particular component in a sample.
  • a biosensor is preferably a glucose sensor employing the coenzyme-binding glucose dehydrogenase.
  • One preferred embodiment of these inventive measurement methods, measurement reagents, measurement compounds and biosensors is characterized by the use of potassium ferricyanide (potassium hexacyanoferrate (III)) at a final concentration of 2 mM to 500 mM.
  • potassium ferricyanide potassium hexacyanoferrate (III)
  • a value of percentage (%) represents “substrate specificity”.
  • a value of percentage (%) represents “substrate specificity”.
  • a value of percentage (%) represents “substrate specificity”.
  • a value also represents for a percentage of a relative intensity of an enzymatic activity on the maltose or other action targets based on the enzymatic activity on glucose being regarded as 100%.
  • FIG. 1 shows a graph representing the relationship between the relative activity (%) of the coenzyme-binding glucose dehydrogenase and the pH, in Example 3 (3.2). Symbols show measured values and types of buffer solutions, which are ⁇ : citric acid-sodium phosphate buffer (pH4.6 to 6.2), ⁇ : potassium phosphate buffer (pH6.8 to 7.2), ⁇ : Tris-HCl buffer (pH7.8 to 8.6) and ⁇ : glycine-sodium hydroxide (pH9.2 to 9.5). The optimum pH of the enzyme was 7.0 to 9.0.
  • FIG. 2 shows a graph representing the relationship between the residual activity (%) of the coenzyme-binding glucose dehydrogenase and the pH, in Example 3 (3.3). Symbols show measured values and types of buffer solutions, which are ⁇ : citric acid-sodium phosphate buffer (pH3.2 to 6.4), ⁇ : potassium phosphate buffer (pH6.3 to 6.9), ⁇ : Tris-HCl buffer (pH7.3 to 8.6) and ⁇ : glycine-sodium hydroxide (pH9.1 to 11.4).
  • the stable pH of the enzyme was 4.5 to 8.5.
  • FIG. 3 shows a graph representing the relationship between the relative activity (%) of the coenzyme-binding glucose dehydrogenase and the temperature, in Example, 3 (3.4).
  • the optimum temperature of the enzyme was approximately 55° C.
  • FIG. 4 shows a graph representing the relationship between the residual activity (%) of the coenzyme-binding glucose dehydrogenase in Example 3 (3.5) and the treatment temperature.
  • the enzyme was revealed to be stable at 50° C. or below.
  • FIG. 5 shows a calibration curve for quantifying the glucose in Example 4, which indicates the change in DCIP absorption vs the glucose level.
  • FIG. 6 shows a calibration curve for a glucose measurement using a coenzyme-binding glucose dehydrogenase-immobilizing electrode in Example 5. Symbols represent the conditions under: x: argon saturation, ⁇ : oxygen saturation and ⁇ : air saturation.
  • An inventive coenzyme-binding glucose dehydrogenase may for example be an enzyme classified as EC 1.1.99, preferably EC 1.1.99.10, EC 1.1.99.13 or EC 1.1.99.17, and is a coenzyme-binding enzyme, preferably a soluble coenzyme-binding enzyme. That is, it is an enzyme capable of being obtained in the state of an aqueous solution without using any surfactant in a step of extraction/purification of the enzyme.
  • a coenzyme may be any flavin compound, such as flavin adenine dinucleotide, flavin mononucleotide and the like.
  • the inventive coenzyme-binding glucose dehydrogenase may be a glucose dehydrogenase to which a coenzyme is bound always over the period of the catalytic reaction.
  • the coenzyme-binding glucose dehydrogenase has at least the following characteristics; that is a physicochemical property for catalyzing a reaction for oxidizing glucose in the presence of an electron acceptor, especially for catalyzing a reaction for oxidizing a hydroxyl group in the 1st-position of the glucose.
  • the coenzyme-binding glucose dehydrogenase has a low activity on maltose, which is at a level for example of 5% or below, preferably 3% or below.
  • the enzymatic activity of the coenzyme-binding glucose dehydrogenase is inhibited by 50% or more at 5 mM of 1,10-phenanthroline, preferably by 50% or more at 2 mM as a final concentration of 1,10-phenanthroline, more preferably by 50% or more at 1 mM of 1,10-phenanthroline, especially by 60% or more at 1 mM of 1,10-phenanthroline.
  • the coenzyme-binding glucose dehydrogenase preserves its residual enzymatic activity at a level as high as 85% or more even after a heat treatment for 15 minutes at 50° C. in the presence of 50 mM sodium citrate buffer solution (pH5.5).
  • the invention relates to coenzyme-binding glucose dehydrogenase having the physicochemical characteristics described above; or an amino acid sequence encoding the physicochemical characteristics, wherein the amino acid sequence is a protein or a salt as follows: the amino acid sequence encoding the protein or the salt contains a mutation resulting from a deletion, substitution or addition of one or more amino acid residues in the sequence, and such the resultant protein and the salt are biologically active and stable, with respect to the protein or its salt having the activity substantially equivalent to that of the coenzyme-binding glucose dehydrogenase.
  • the protein or its salt, which are the inventive coenzyme-binding glucose dehydrogenase is preferably one derived from a microorganism having the physicochemical characteristics described above.
  • a microorganism from which the inventive coenzyme-binding glucose dehydrogenase is derived and a microorganism having an ability of producing the inventive coenzyme-binding glucose dehydrogenase may for example be those classified into prokaryotic microorganisms such as genus Archangium , genus Arcaeoglobus , genus Arsenophonus , genus Ahrensia , genus Aureobacterium , genus Aerococcus , genus Aeropyrum , genus Aeromicrobium , genus Aeromonas , genus Aquifex , genus Aquaspirillum , genus Aquabacter , genus Aquabacterium , genus Aquamicrobium , genus Act
  • eukaryotic microorganisms such as genus Issatchenkia, Candida , genus Cryptococcus , genus Kluyverintces , genus Kloeckera , genus Saccharomycodes , genus Saccharomyces , genus Zygosaccharomyces , genus Shizosaccharomyces , genus Sirobasidium , genus Strigmatomyces , genus Sporidobolus , genus Sporobolomyces , genus Dekkera , genus Debaryomyces , genus Trichosporon , genus Trigonopsis , genus Torulaspora , genus Tremella , genus Nadsonia , genus Nematospora , genus Hanseniaspora , genus Pichia , genus Fibulobasidium
  • a microorganism listed above which has an ability of producing an inventive coenzyme-binding glucose dehydrogenase has been deposited under its accession number to IFO, ATCC and the like, and can be obtained from known distributors and corporations.
  • Such a microorganism may for example be a eukaryotic microorganism, more preferably mycotic microorganism. It is also possible to use the microorganism which is designated as “97508” and was deposited under FERM BP-08578 to International Patent Organism Depositary of National Institute of Advanced Industrial Science and Technology.
  • a microorganism having an ability of producing the inventive coenzyme-binding glucose dehydrogenase is cultured in a nutrition medium, in which the coenzyme-binding glucose dehydrogenase is allowed to be produced and accumulated, and then recovered to yield a protein which is the coenzyme-binding glucose dehydrogenase and its salt.
  • the deposited inventive strain FERM BP-08578, a coenzyme-binding glucose dehydrogenase derived therefrom, and a method for obtaining the enzyme are described below.
  • the electron acceptor may for example be phenazine methosulfate, 1-methoxy-5-methylphenazinium methyl sulfate, 2,6-dichlorophenolindophenol, ferricyanides and the like.
  • Substrate specificity The relative reactivity (substrate specificity) of the inventive enzyme when using D-glucose and other substrates (all at the final concentration of 333 mM except for D-cellobiose at 193 mM, D-trehalose and D-raffinose at 121 mM) by the activity measurement method 1 described below are shown in Table 1.
  • the relative reactivity (substrate specificity) when using D-glucose and maltose at the final concentrations of 550 mM and 100 mM are shown in Table 2.
  • D-glucose A higher activity was observed on D-glucose, while lower activity were observed on D-mannose, 1,5-anhydro-D-glucitol, D-cellobiose, D-trehalose, maltose, D-galactose, D-glucose-6-phosphate and D-fructose. Almost no activity was observed on L-arabinose, lactose, D-sorbitol, gluconic acid, sucrose, D-mannitol, L-sorbose, D-ribose, L-rhamnose, D-glucose-1-phosphate, D-raffinose, ethanol or glycerol.
  • pH for stability pH4.5 to pH8.5.
  • Optimum temperature Approximately 55° C.
  • Thermal stability Stable at 50° C. or below.
  • Molecular weight About 130 kDa when measured by a gel filtration method, and about 85 kDa when measured by a sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
  • Km value 49.7 mM (D-glucose).
  • Isoelectric point The isoelectric point (pI) of the coenzyme-binding glucose dehydrogenase measured by an isoelectric focusing was about 4.4.
  • amino acid sequence of the coenzyme-binding glucose dehydrogenase and the base sequence of a gene encoding it are also encompassed by the invention.
  • a microorganism for producing the coenzyme-binding glucose dehydrogenase may be any microorganism as far as it can produce the inventive coenzyme-binding glucose dehydrogenase, and the enzyme can efficiently be produced by using a microorganism, preferably a eukaryotic microorganism, more preferably a mycotic microorganism. It is especially preferred to use the microorganism which is designated as “97508” and was deposited under FERM BP-08578 to International Patent Organism Depositary of National Institute of Advanced Industrial Science and Technology. The deposited strain was isolated from a soil by Applicants, and has the mycological characteristics as described below. In the invention, any variant of the strain mentioned above may also be employed. Such a variant can be obtained for example by the irradiation with an ultraviolet light or X-ray or the treatment with a chemical modifier (NTG and the like).
  • Morphological characteristics The morphological profile of the present strain when observed by an optical microscope after allowed to grow on a potato dextrose agar medium is described below. Each mycelium has a width of 2 ⁇ m to 4 ⁇ m, and has a regular septum. Most of the mycelia grow linearly, and have branches with almost no swollen mycelia being observed. Several mycelia are gathered together to form a mycelial bundle. The mycelial width is almost constant. The surface of a mycelium is smooth and the septum is slightly thick. A crystalloid is formed around the root of the aerial mycelia. No clamp connection is formed.
  • the mycotic body formed in 2-week culture exhibited no formation of any sexual or asexual reproductive organs, and no oidia or thick-walled spores are present.
  • (2) Growth condition in various culture media On all agar plates, each mycelium is in a form of a fluff. The aerial mycelium shade is white. On the potato dextrose agar plate, the backside color is pale orange to orange. The growth magnitude is medium, and a colony after culturing at 25° C. for 1 week has a diameter of 30 mm to 35 mm on the potato dextrose and oatmeal agar plates, and 37 mm to 38 mm on the malt extract agar plate.
  • the production of soluble pigments of a pale yellow color on the potato dextrose agar plate and a slightly reddish to grey-reddish color on the oatmeal agar plate was noted.
  • the mycotic body formed in 2-week culture exhibited no formation of reproductive organs such as a conidiophore, and no exudate was produced.
  • the present strain is an aerobic one and has an optimum growth temperature of about 37° C. on the potato dextrose agar plate.
  • the deposited strain “97508” was characterized with referring to Ainsworth 86 Bisby's Dictionary of the Fungi, 7th edition (Ed. by Hawksworth, Sutton, Ainsworth). As a result of this characterization, the deposited strain was revealed to be a microorganism classified into the genus Aspergillus . Then its genome sequence was subjected to BLAST homology search. An 18S rDNA fragment was amplified using a genome DNA as a template by PCR method, and then sequence of the purified PCR product was analyzed.
  • GenBank GenBank/EMBL/DDBJ international DNA sequence database
  • BLAST Altschul et al., 1997) homology search was conducted, and revealed that this deposited strain “97508” is Aspergillus terreus.
  • the microorganism described above is cultured to allow the coenzyme-binding glucose dehydrogenase to be expressed or produced by the microorganism in internal and/or external of its fungus body.
  • any ordinary culture medium for microorganism may be used.
  • Such medium may include a synthetic or natural medium, as long as it contains suitable amounts of carbon sources, nitrogen sources, inorganic substances and other trace elements required by the microorganism.
  • the carbon sources may be glucose, sucrose, dextrin, starch, glycerin, syrup and the like.
  • the nitrogen sources may be inorganic salts such as ammonium chloride, ammonium nitrate, ammonium sulfate and ammonium phosphate, amino acids such as DL-alanine and L-glutamic acid, as well as nitrogen-containing natural materials such as peptone, meat extract, yeast extract, malt extract, corn steep liquor and the like.
  • the inorganic materials may for example be monosodium phosphate, disodium phosphate, monopotassium phosphate, dipotassium phosphate, magnesium sulfate, ferric chloride and the like.
  • the culture in order to obtain the inventive coenzyme-binding glucose dehydrogenase is conducted preferably in an aerobic condition for example by a shaking or aerating culture at a temperature of 25° C. to 60° C. at a pH of 5 to 8.
  • the culture period ranges preferably from 2 days to 4 days.
  • the coenzyme-binding glucose dehydrogenase can be produced and accumulated in the culture, especially in a culture fluid.
  • the coenzyme-binding glucose dehydrogenase can be produced by the microorganism and accumulated also internal fungus body.
  • the coenzyme-binding glucose dehydrogenase can be recovered from the culture by means of an ordinary protein purification method.
  • a method may be a method comprising incubating the microorganism followed by removing the microorganism for example by a centrifugation to obtain a supernatant, or a method comprising incubating the microorganism, recovering the cultured microorganism from the culture fluid by a centrifugation, crushing the cultured microorganism by a suitable method, and then isolating a supernatant for example by a centrifugation from the pelletized microorganism fluid.
  • the coenzyme-binding glucose dehydrogenase contained in such a supernatant can be purified by a combination of suitable purification procedures such as salting out, solvent sedimentation, dialysis, ion exchange chromatography, hydrophobic adsorption chromatography, gel filtration, affinity chromatography, electrophoresis and the like.
  • a solid medium can be also used.
  • the method for such a culture is not limited particularly, and may for example be a static culture, or a dynamic culture involving a continuous agitation of the culture, such as a rotational culture or fluidized bed culture, with a static culture being preferred due to a less expensive investment in equipment.
  • an ordinary protein purification method can be adopted as a method of obtaining the coenzyme-binding glucose dehydrogenase from the culture. That is, the culture is combined with water or other extraction medium and shaken, made free of any solid components such as bran by means of a centrifugation or filtration, thereby yielding an extract.
  • the coenzyme-binding glucose dehydrogenase accumulated in the fungus bodies can be recovered by grinding the culture residue after obtaining the extract described above together with a an abrasive compound such as a sea sand, followed by adding water to extract the coenzyme-binding glucose dehydrogenase released from the fungus bodies.
  • abrasive compound such as a sea sand
  • the entire culture is ground with an abrasive compound such as a sea sand, followed by adding water to extract both of the coenzyme-binding glucose dehydrogenase released from the fungus bodies and the coenzyme-binding glucose dehydrogenase secreted into the culture all at once.
  • the coenzyme-binding glucose dehydrogenase contained in such a supernatant can be purified by a combination of suitable purification procedures such as salting out, solvent sedimentation, dialysis, ion-exchange chromatography, hydrophobic adsorption chromatography, gel filtration, affinity chromatography, electrophoresis and the like.
  • the inventive coenzyme-binding glucose dehydrogenase may also be a synthetic coenzyme-binding glucose dehydrogenase or a recombinant coenzyme-binding glucose dehydrogenase obtained by a gene engineering technology.
  • Those skilled in the art can obtain the coenzyme-binding glucose dehydrogenase readily based on the disclosure of the protein or its salt derived from the physicochemical characteristics of the inventive coenzyme-binding glucose dehydrogenase.
  • the coenzyme-binding glucose dehydrogenase can be extracted from a microorganism including a fungi or a naturally occurring material such as an animal or plant, or can be obtained synthetically with referring to the amino acid sequence or the base sequence of the gene encoding it.
  • coenzyme-binding glucose dehydrogenase industrially using a gene engineering method in which a gene segment of the coenzyme-binding glucose dehydrogenase gene is inserted into a known expression vector such as a commercial expression vector and then the resultant plasmid is used to transform a host such as Escherichia coli to obtain a transformant which is then cultured to obtain a target coenzyme-binding glucose dehydrogenase.
  • the enzyme is diluted appropriately to a final concentration of 0.1 to 1 unit/ml.
  • the enzymatic activity unit of the enzyme is the enzymatic activity enabling the oxidation of 1 ⁇ mol glucose per minute.
  • the enzymatic activity of the inventive coenzyme-binding glucose dehydrogenase can be measured by the method shown below.
  • D-gluconic acid in the solution was converted into D-glucono- ⁇ -lactone, and thereafter combined with 0.39 ml of a 100 mM Tris-HCl buffer (pH7.5) and 0.01 ml of 1.0N hydrochloric acid to achieve a neutral pH.
  • the D-gluconic acid in the solution was quantified using the D-gluconic acid/D-glucono- ⁇ -lactone measurement kit (Boehringer Mannheim). Since the enzymatic activity corresponding to the production of 1 ⁇ mol of D-glucono- ⁇ -lactone per minute is equivalent substantially to 1 unit of this enzyme, this enzymatic activity was determined based on the amount of D-glucono- ⁇ -lactone produced.
  • the invention relates to a material production and an analytical application employing an inventive coenzyme-binding glucose dehydrogenase, and also relates to the use in the modification of pharmaceutical or food product materials.
  • the use is made in a method for eliminating glucose in a sample containing a biological material using the coenzyme-binding glucose dehydrogenase as a reagent, a measurement method as well as in such a reagent or a reagent composition.
  • the use is made also in a method for producing an organic compound using the inventive coenzyme-binding glucose dehydrogenase as well as in a basic ingredient therefor.
  • the inventive coenzyme-binding glucose dehydrogenase is the enzyme that catalyzes a reaction for oxidizing glucose in the presence of an electron acceptor.
  • the reaction mentioned above employs the inventive coenzyme-binding glucose dehydrogenase.
  • a coenzyme-binding glucose dehydrogenase is not limited particularly, and is preferably a coenzyme-binding glucose dehydrogenase derived from a eukaryotic microorganism producing the coenzyme-binding glucose dehydrogenase, with a coenzyme-binding glucose dehydrogenase derived from a mycotic microorganism being preferred especially.
  • the coenzyme-binding glucose dehydrogenase is the enzyme that catalyzes a reaction for oxidizing glucose in the presence of an electron acceptor, any application in which the change resulting from such a reaction can be utilized can be mentioned.
  • the coenzyme-binding glucose dehydrogenase can be used in a reagent for measuring or eliminating glucose in a sample containing a biological material. It is also possible to use in medical and clinical fields, and also in the material production and analysis employing the coenzyme-binding glucose dehydrogenase.
  • the inventive biosensor may be any sensor having a reaction layer containing the inventive coenzyme-binding glucose dehydrogenase as an enzyme.
  • the biosensor can be produced in a method wherein an enzymatic reaction layer formed thereon containing a hydrophilic polymer, a redox enzyme and an electron acceptor is brought into contact with an electrode system consisting of an action electrode, a counter electrode and a reference electrode is formed for example by a screen printing on an insulating board.
  • an electrode system consisting of an action electrode, a counter electrode and a reference electrode is formed for example by a screen printing on an insulating board.
  • the biosensor After completion of the enzymatic reaction, the reduced electron acceptor is oxidized electrochemically, whereupon the biosensor can measure the concentration of the substrate in the sample based on the resultant oxidation current value. Otherwise, a biosensor can be constructed so that the chromogenic intensity or pH change is detected.
  • any of various materials can be measured by selecting the enzyme whose substrate is the target substance. For example, when the inventive coenzyme-binding glucose dehydrogenase is selected as an enzyme, a glucose sensor enabling the measurement of the concentration of glucose in a sample solution can be produced.
  • a chemical substance having an excellent ability of transferring an electron can be employed as the electron acceptor in the biosensor.
  • Such a chemical substance having an excellent ability of transferring an electron is generally a substance referred to as “electron carrier”, “mediator” or “oxidation/reduction(redox)-mediating agent”, such as the electron transfer and the redox-mediating agent listed in JP-W-2002-526759.
  • an inexpensive potassium ferricyanide (potassium hexacyanoferrate (III)) is generally employed as an electron acceptor, and usually used at a final concentration of 1 mM or less.
  • the inventive coenzyme-binding glucose dehydrogenase enables a more sensitive measurement of D-glucose when using potassium ferricyanide at a concentration as high as 2 to 500 mM, more preferably 30 to 100 mM.
  • a preferred embodiment of the inventive measurement method, measurement reagent, measurement compound, biosensor and the like is characterized by the use of potassium ferricyanide in its relevant measurement system at a final concentration of 2 to 500 mM.
  • Example 1 160 L of the culture supernatant of Example 1 was concentrated through an ultrafiltration membrane “Pellicon 2 Module” (Millipore), and transferred into a 20 mM potassium phosphate buffer (pH7.5) to obtain a crude enzyme solution.
  • the abovementioned crude enzyme solution was prepared in 65%-saturated ammonium sulfate (pH7.5), and centrifuged to obtain a supernatant.
  • This treated crude enzyme solution was loaded onto a Butyl-TOYOPEARL 650M column (diameter: 4.7 cm, height: 7.7 cm) which had previously been equilibrated with a 20 mM potassium phosphate buffer (pH7.5) containing 65% ammonium sulfate; and thereby allowing the enzyme is absorbed therein.
  • This column was washed with the same buffer solution, and then the enzyme was allowed to be eluted with 20 mM potassium phosphate buffer (pH7.5) containing 30% ammonium sulfate to collect an active fraction.
  • the enzyme was further eluted by a gradient elution starting from the same buffer to 20 mM potassium phosphate buffer (pH7.5), and pooled with the former active fraction.
  • the abovementioned active fraction was concentrated through an ultrafiltration membrane “Pellicon 2 Module”, desalted, and equilibrated with a 15 mM Tris-HCl buffer (pH8.5). This fraction was loaded onto a DEAE-CELLULOFINE A-500 column (diameter: 4.7 cm, height: 5.2 cm) which had previously been equilibrated with the same buffer solution, and the eluate was collected.
  • the abovementioned eluate was prepared in 65%-saturated ammonium sulfate (pH7.5), and centrifuged to obtain a supernatant.
  • This supernatant was loaded onto a Butyl-TOYOPEARL 650M column (diameter: 4.7 cm, height: 3.6 cm) which had previously been equilibrated with a 20 mM potassium phosphate buffer (pH7.5) containing 65% ammonium sulfate; thereby allowing the enzyme is absorbed.
  • This column was washed with the same buffer solution, and then the enzyme was allowed to be eluted with 20 mM potassium phosphate buffer (pH7.5) containing 30% ammonium sulfate to collect an active fraction.
  • the abovementioned active fraction was concentrated through a pencil type membrane concentration module “ACP-0013” (ASAHI KASEI), desalted, and equilibrated with 50 mM potassium phosphate buffer (pH5.5) containing 0.2M sodium chloride. This fraction was loaded onto a TSKgel G3000SW (diameter: 2.15 cm, height: 60 cm) which had previously been equilibrated with the buffer described above, and the enzyme was eluted with the same buffer to obtain an active fraction.
  • the active fraction was concentrated through a centriplus 10 (Amicon), desalted, and transferred into a 50 mM citric acid-sodium phosphate buffer (pH5.5).
  • the resultant enzyme approximately had a specific activity of 1,100 unit/mg, and a purification degree of about 170 times greater than that of the crude enzyme solution.
  • Example 2 The coenzyme-binding glucose dehydrogenase isolated in Example 2 described above was examined for its effect, optimum pH, pH for stability, optimum temperature, thermal stability, substrate specificity, molecular weight, inhibitor and coenzyme.
  • the coenzyme-binding glucose dehydrogenase was reacted with 500 mM D-glucose in the presence of 8.66 mM DCIP, and the reaction product was quantified using D-gluconic acid/D-glucono- ⁇ -lactone measurement kit. As a result, the production of D-gluconic acid was identified, and it was revealed that the inventive coenzyme-binding glucose dehydrogenase is the enzyme that catalyzes a reaction for oxidizing a hydroxyl group in the 1-position of D-glucose.
  • the buffer solution according to the Enzymatic activity measurement method 2 was replaced with the citric acid-sodium phosphate buffer (pH4.0 to 5.5), potassium phosphate buffer (pH6.5 to 7.5), Tris-HCl buffer (pH8.0 to 9.0) or glycine-sodium hydroxide buffer (pH9.5 to 10.0) (each 17 mM as a final concentration), and the enzymatic activity of the purified enzyme was measured at various pH ranges similarly to Enzymatic activity measurement method 2 ( FIG. 1 ). As a result, the optimum pH of the coenzyme-binding glucose dehydrogenase was 7.0 to 9.0.
  • the coenzyme-binding glucose dehydrogenase was dissolved in each 50 mM buffer, i.e., citric acid-sodium phosphate buffer (pH3.2 to 6.4), potassium phosphate buffer (pH6.3 to 6.9), Tris-HCl buffer (pH7.3 to 8.6) or glycine-sodium hydroxide buffer (pH9.1 to 11.4) and kept at 40° C. for 60 minutes, and then the enzymatic activity was examined by the method according to the activity measurement method 1, and a ratio of residual enzymatic activity was analyzed ( FIG. 2 ). As a result, the pH for the stability of the coenzyme-binding glucose dehydrogenase was pH4.5 to 8.5.
  • the coenzyme-binding glucose dehydrogenase was dissolved in 50 mM citric acid-sodium phosphate buffer (pH5.5) and examined for the enzymatic activity over the range from 30° C. to 62° C. by the Enzymatic activity measurement method 1 described above ( FIG. 3 ). As a result, the optimum temperature of the coenzyme-binding glucose dehydrogenase was about 55° C.
  • the coenzyme-binding glucose dehydrogenase was dissolved in 50 mM citric acid-sodium phosphate buffer (pH5.5), kept at several points of the temperature ranging from 0° C. to 55° C. for 15 minutes, and then examined for the enzymatic activity by the Enzymatic activity measurement method 1, and the ratio (%) of residual enzymatic activity was analyzed ( FIG. 4 ).
  • the ratio (%) of residual enzymatic activity was calculated with regarding the enzymatic activity after keeping at 0° C. for 15 minutes as 100%.
  • the coenzyme-binding glucose dehydrogenase kept its enzymatic activity at a level as high as 89% even at 50° C., showing the stability at about 50° C. or below.
  • the coenzyme-binding glucose dehydrogenase acts potently on D-glucose, and weakly on D-mannose, 1,5-anhydro-D-glucitol, D-cellobiose, D-trehalose, maltose, D-galactose, D-glucose-6-phosphate and D-fructose.
  • This enzyme exhibited almost no effect on L-arabinose, lactose, D-sorbitol, gluconic acid, sucrose, D-mannitol, L-sorbose, D-ribose, L-rhamnose, D-glucose-1-phosphate, D-raffinose, ethanol or glycerol.
  • the Km value of this enzyme was 49.7 mM on D-glucose.
  • the coenzyme-binding glucose dehydrogenase was dissolved in a 50 mM potassium phosphate buffer (pH7.5) containing 0.2M NaCl, and analyzed on a TSKgel-G3000SW (diameter: 0.75 cm, length: 60 cm, TOSOH) using the same buffer solution as a mobile phase.
  • a molecular weight marker Oriental Yeast
  • the molecular weight of the coenzyme-binding glucose dehydrogenase was revealed to be about 130 kDa.
  • the inventive coenzyme-binding glucose dehydrogenase was subjected to an SDS-polyacrylamide gel electrophoresis (SDS-PAGE) according to the method by Laemmli et al (Nature, (1970) 227:680-685). After the running, the gel was stained with Coomassie brilliant blue, and the mobility was compared with that of the molecular weight marker (Amersham Pharmacia Biotech), which revealed that the subunit molecular weight of the inventive coenzyme-binding glucose dehydrogenase was about 85 kDa.
  • SDS-PAGE SDS-polyacrylamide gel electrophoresis
  • Each of the various additives shown in Table 3 was added as an inhibitor at 1 mM as a final concentration to the reaction system of the Enzymatic activity measurement method 1, and the activity of the coenzyme-binding glucose dehydrogenase was measured by the Enzymatic activity measurement method 1.
  • the procedure similar to that of Enzymatic activity measurement method 1 was conducted except for adding no additives shown in Table 3.
  • the activity in the presence of each additive was calculated as a relative activity, the difference of which from the control group activity was regarded as a % inhibitory effect.
  • the inhibitory effect shown in Table 3 was observed.
  • 1,10-phenanthroline was as high as 62.0% at 1 mM, 76% at 5 mM, 85% at 10 mM, 91% at 25 mM and 95% at 50 mM as final concentrations of 1,10-phenanthroline.
  • the inhibitory effect on the inventive coenzyme-binding glucose dehydrogenase varied depending on the type of the additive, and was the highest in the presence of heavy metal ion (such as Ag + , Cu 2+ and Hg 2+ ), and was 60% or more in the presence of 1,10-phenanthroline, proflavin and Mn 2+ .
  • heavy metal ion such as Ag + , Cu 2+ and Hg 2+
  • the inventive coenzyme-binding glucose dehydrogenase solution was supplemented with D-glucose and subjected to the absorption analysis, which indicated the disappearance of the maximum absorptions observed at 385 nm and 465 nm in response to the supplement, revealing that the coenzyme was flavin adenine dinucleotide. These maximum absorptions are specific to FAD, and it was not observed in a control group reaction system constructed by excluding FAD only.
  • the coenzyme-binding glucose dehydrogenase derived from the deposited strain 97508 purified in Example 2 described above was employed, and the absorption reduction rate was measured using D-glucose at the concentration ranging from 0.333 to 33 mM instead of 333 mM D-glucose in the Enzymatic activity measurement method 1.
  • the transition in the absorption was measured at each D-glucose concentration of 0.333 mM, 0.5 mM, 1 mM, 2 mM, 5 mM, 6.67 mM, 10 mM, 20 mM and 33 mM.
  • the results of the measurement are shown in FIG. 5 .
  • the coenzyme-binding glucose dehydrogenase derived from the deposited strain 97508 purified in Example 2 described above was employed to measure D-glucose by an enzyme-immobilizing electrode.
  • a glassy carbon (GC) electrode on which 3.4 U of this enzyme was immobilized was employed to measure the response current to the glucose concentration.
  • GC glassy carbon
  • 2.7 ml of 100 mM sodium phosphate buffer (pH7.0) and 0.3 ml of 1M aqueous solution of potassium hexacyanoferrate (III) (potassium ferricyanide) were added.
  • the GC electrode was connected to the potentiostat BAS100B/W (BAS), and the solution was stirred at 40° C.
  • the concentration of glucose in a serum was measured by the enzyme-immobilizing electrode using the control serum I WAKO B (WAKO PURE CHEMICAL).
  • control serum I WAKO B WAKO PURE CHEMICAL
  • 2.4 ml of 100 mM sodium phosphate buffer (pH7.0) and 0.3 ml of 1M aqueous solution of potassium hexacyanoferrate (III) (potassium ferricyanide) were added, and the serum was added when the current value became stationary and the current value was measured.
  • the D-glucose solutions of known concentrations were measured to obtain a calibration curve.
  • the glucose concentration in the serum was identified by the calibration curve method to be 4.5 mM, which was in agreement with the concentration of the glucose identified by the hexokinase-glucose-6-phosphate dehydrogenase method. Accordingly, it was revealed that the quantification of D-glucose in serum by the enzyme-immobilizing electrode employing the coenzyme-binding glucose dehydrogenase employed in the invention is possible.
  • a soluble coenzyme-binding glucose dehydrogenase whose activity on altose is 5% or less and which is inhibited by 1,10-phenanthroline. Furthermore, a method for producing the coenzyme-binding glucose dehydrogenase suitable to an industrial production and a microorganism producing therefor are also provided. As a result, it becomes possible to apply the coenzyme-binding glucose dehydrogenase to an industrial application, and more particularly, it becomes possible to measure the blood sugar level even in a diabetes patient receiving an infusion containing maltose.
  • a trace amount of the glucose can be measured even with a glucose sensor, thus enabling the utility. It also becomes possible to use in a material production or analysis including a method for measuring or eliminating glucose in a sample using the coenzyme-binding glucose dehydrogenase as well as a method for producing an organic compound, thereby providing a highly utilizable enzyme, which enables use for modifying a material in the fields of pharmaceuticals, clinical studies and food products.

Abstract

The present invention provides a microorganism-derived soluble coenzyme-binding glucose dehydrogenase which catalyzes a reaction for oxidizing glucose in the presence of an electron acceptor, has an activity to maltose as low as 5% or less, and is inhibited by 1,10-phenanthroline. The invention also provides a method for producing the coenzyme-binding glucose dehydrogenase, and a method and a reagent for measuring employing the coenzyme-binding glucose dehydrogenase. According to the invention, the coenzyme-binding glucose dehydrogenase can be applied to an industrial field, and a use becomes possible also in a material production or analysis including a method for measuring or eliminating glucose in a sample using the coenzyme-binding glucose dehydrogenase as well as a method for producing an organic compound. It became also possible to provide a glucose sensor capable of accurately measuring a blood sugar level. Therefore, it became possible to provide an enzyme having a high utility, such as an ability of being used for modifying a material in the fields of pharmaceuticals, clinical studies and food products.

Description

    TECHNICAL FIELD
  • The present invention relates to a novel soluble coenzyme-binding glucose dehydrogenase, a method for producing the coenzyme-binding glucose dehydrogenase, and a microorganism having an ability of producing the coenzyme-binding glucose dehydrogenase.
  • The invention also relates to a method for measuring glucose in a sample employing the coenzyme-binding glucose dehydrogenase, and a reagent and a reagent composition containing the coenzyme-binding glucose dehydrogenase. Moreover, the invention relates to utilization in producing and analyzing a material such as a starting material, including a method for producing an organic compound.
  • The invention further relates to a biosensor capable of rapidly and conveniently quantifying a particular component in a sample at a high accuracy. Practically, the invention relates to a glucose sensor employing the coenzyme-binding glucose dehydrogenase.
  • BACKGROUND ART
  • Glucose is present in blood and utilized as an important marker for diabetes. A method for measuring a glucose has conventionally been a chemical method or an enzymatic method, and an enzymatic method is regarded generally to be excellent in view of the specificity and the safety. Such an enzymatic method is, for example, be a measurement using a glucose oxidase, glucose-6-phosphate dehydrogenase or an NAD(P)-dependent glucose dehydrogenase. However, the methods employing the glucose oxidase and the glucose-6-phosphate dehydrogenase are not convenient reaction systems since they employ a plural of enzymes. The methods employing the glucose-6-phosphate dehydrogenase and the NAD(P)-dependent glucose dehydrogenase pose a complication due to the requirement of adding a coenzyme NAD(P) to the reaction systems.
  • Recently, various biosensors were proposed as modes for quantifying a particular component in a sample conveniently without diluting or stirring a sample solution. For example, a biosensor was proposed in which an electrode system consisting of an action electrode, a counter electrode and a reference electrode was formed by a screen printing on an insulating board. This electrode system and the like was in contact with an enzymatic reaction layer formed thereon containing a hydrophilic polymer, a redox enzyme and an electron acceptor.
  • The number of diabetes patient is increasing year by year, and a method for measuring a blood sugar and a means for controlling the blood sugar level are desired which can be utilized not only in a hospital but also at home and which is convenient. While a simple glucose sensor is employed currently for measuring the blood sugar, it frequently employs a glucose oxidase which is highly suspected to give a measured value involving an error due to a level of the residual oxygen. On the other hand, a biosensor employing a glucose dehydrogenase which is dependent on a nicotinamide-based coenzyme exhibits a high background noise and involves a complicated reaction system due to the requirement of adding a coenzyme or an auxiliary enzyme separately, and it also suffers from a disadvantage due to the requirement of an expensive optical system upon measuring a chromogenic system.
  • As an enzyme which is not affected by the residual oxygen level and which can act on glucose in the absence of NAD(P), a glucose dehydrogenase whose coenzyme is pyrroloquinolinequinone is known, but the pyrroloquinolinequinone problematically tends to dissociate from the A glucose dehydrogenase whose coenzyme is pyrroloquinolinequinone disclosed in JP-A-2000-350588 and JP-A-2001-197888 has a disadvantageously low selectivity for glucose. On the other hand, a glucose dehydrogenase whose coenzyme is the pyrroloquinolinequinone derived from Escherichia coli (JP-A-10-243786), a glucose dehydrogenase whose coenzyme is the pyrroloquinolinequinone derived from Pseudomonas sp. (Agric. Biol. Chem. (1980) 44:1505-1512) and a glucose dehydrogenase whose coenzyme is the pyrroloquinolinequinone derived from Gluconobacter suboxydans (Agric. Biol. Chem. (1981) 45:851-861) had the respective activity on maltose of 3%, 3.2% and 5%, but were accompanied with the complication due to the requirement of a solubilization and an extraction of the enzymes since they were existing in a membrane fraction of the bacterial bodies.
  • The coenzyme-binding glucose dehydrogenases which oxidize a hydroxyl group in the 3rd-position of glucose were also reported in J. Biol. Chem. (1967) 242: 3665-3672, Appl. Microbiol. Biotechnol. (1999) 51: 58-64, Appl. Biochem. Biotechnol. (1996) 56: 301-310 and Enzyme Microb. Technol. (1998) 22:269-274, but any of them exhibits a poor selectivity for glucose. Since maltose is employed widely as an infusion component and the blood maltose level in an infused patient is high, it is desired to develop an enzyme for measuring the blood sugar which is capable of acting specifically on glucose and has low activity especially on maltose.
  • In order to respond the industrial needs mentioned above, an objective of the invention is to provide a novel glucose dehydrogenase which exhibits an excellent substrate-recognizing ability toward glucose and which has low activity on maltose, and also to provide a method for producing the same and a microorganism having an ability of producing the same.
  • Another objective of the invention is to provide excellent glucose measuring method, measuring reagent and biosensor which employ the novel glucose dehydrogenase and which are capable of quantifying glucose rapidly and conveniently at a high accuracy, as well as a glucose-eliminating reagent.
  • DISCLOSURE OF THE INVENTION
  • The invention is accomplished for solving the problems mentioned above, and the inventors made an effort in various ways and then focused on a novel soluble coenzyme-binding glucose dehydrogenase. The coenzyme-binding glucose dehydrogenase catalyzes a glucose-oxidizing reaction in the presence of an electron acceptor, and is classified for example as EC (Enzyme Code) 1.1.99. The inventors also made an effort in characterizing various microorganisms producing the coenzyme-binding glucose dehydrogenase, and finally discovered a coenzyme-binding glucose dehydrogenase-producing microorganism and a coenzyme-binding glucose dehydrogenase.
  • The invention provides a glucose dehydrogenase to which a coenzyme is bound continuously upon a catalytic reaction. The coenzyme-binding glucose dehydrogenase has a physicochemical ability of catalyzing a reaction for oxidizing glucose, especially a hydroxyl group in the 1st-position of glucose, in the presence of an electron acceptor. The coenzyme-binding glucose dehydrogenase has 5% or less activity to maltose, preferably 3% or less; thus it has a poor activity on the maltose. On the other hand, the coenzyme-binding glucose dehydrogenase allows its enzymatic activity to be inhibited characteristically by 50% or more at 5 mM of 1,10-phenanthroline, preferably by 50% or more at 2 mM as a final concentration of 1,10-phenanthroline, more preferably by 50% or more at 1 mM of 1,10-phenanthroline. The coenzyme-binding glucose dehydrogenase preserves its residual enzymatic activity at a level as high as 85% or more even after a heat treatment for 15 minutes at 50° C. in the presence of 50 mM sodium citrate buffer solution (pH5.5). The coenzyme which is bound to the inventive glucose dehydrogenase may for example be a flavin compound, including a coenzyme such as flavin adenine dinucleotide. The invention also includes, with respect to a protein having the characteristics of those of the coenzyme-binding glucose dehydrogenase and/or characteristics equivalent substantially thereto as well as its salt, a protein which has an amino acid sequence encoding the protein or an amino acid sequence containing a mutation resulting from a deletion, substitution or addition of one or more amino acid residues in the sequence and which is biologically active and stable. Moreover, the inventive coenzyme-binding glucose dehydrogenase is a microorganism-derived coenzyme-binding glucose dehydrogenase, preferably a eukaryotic microorganism-derived coenzyme-binding glucose dehydrogenase, more preferably the deposited strain FERM BP-08578-derived coenzyme-binding glucose dehydrogenase.
  • It has already been observed that a glucose dehydrogenase whose coenzyme is a flavin adenine dinucleotide exists in a cytoplasm fraction and a culture of Aspergillus oryzae (TCHAN-GI BAK (BIOCHEMICA ET BIOPHYSICA ACTA. (1967) 139:277-293)). However, this glucose dehydrogenase is inhibited only by a heavy metal ion, and characterized physicochemically in that it is not inhibited by a metal chelator including 1,10-phenanthroline. Accordingly, in a measurement system employing this glucose dehydrogenase, only a heavy metal can be used as a quencher, which poses a problem associated with a complicated heavy metal waste disposal after completion of the reaction. In addition, this enzyme has a poor stability, and is problematic when used practically. On the other hand, the coenzyme-binding glucose dehydrogenase discovered in this invention is characterized by its higher stability when compared with that of the known Aspergillus oryzae-derived coenzyme-binding glucose dehydrogenase, and also by a favorably convenient handling for quenching because of its ability of being inhibited by a trace amount of 1,10-phenanthroline in addition to a heavy metal ion.
  • The invention provides a method for producing the novel soluble coenzyme-binding glucose dehydrogenase.
  • The invention provides a microorganism having an ability of producing the novel soluble coenzyme-binding glucose dehydrogenase. The microorganism is preferably a eukaryotic microorganism, more preferably, genus Aspergillus, further preferably, Aspergillus terreus, and most preferably, the deposited strain FERM BP-08578.
  • The invention provides a method using the novel soluble coenzyme-binding glucose dehydrogenase. Preferably, a method for measuring glucose using the coenzyme-binding glucose dehydrogenase is provided for measuring glucose in a sample. A method for eliminating glucose using the coenzyme-binding glucose dehydrogenase and a method for producing an organic compound are also provided.
  • The invention provides a reagent containing the novel soluble coenzyme-binding glucose dehydrogenase. The reagent is preferably a glucose-measuring reagent containing the coenzyme-binding glucose dehydrogenase employed for measuring the glucose in a sample, and a glucose-eliminating reagent containing the coenzyme-binding glucose dehydrogenase as well as an organic compound-producing reagent.
  • The invention provides a reagent composition containing the novel soluble coenzyme-binding glucose dehydrogenase. The composition is preferably a glucose-measuring composition containing the coenzyme-binding glucose dehydrogenase employed for measuring glucose in a sample, and a glucose-eliminating composition containing the coenzyme-binding glucose dehydrogenase as well as an organic compound-producing composition.
  • The invention provides a biosensor employing the novel soluble coenzyme-binding glucose dehydrogenase and a biosensor capable of quantifying and/or qualifying a particular component in a sample. Such a biosensor is preferably a glucose sensor employing the coenzyme-binding glucose dehydrogenase.
  • One preferred embodiment of these inventive measurement methods, measurement reagents, measurement compounds and biosensors is characterized by the use of potassium ferricyanide (potassium hexacyanoferrate (III)) at a final concentration of 2 mM to 500 mM.
  • In the invention, a value of percentage (%) represents “substrate specificity”. For example, in the expressions “activity to maltose”, “activity” toward maltose” or an analogous expression, according to the coenzyme-binding glucose dehydrogenase, such a value also represents for a percentage of a relative intensity of an enzymatic activity on the maltose or other action targets based on the enzymatic activity on glucose being regarded as 100%.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 shows a graph representing the relationship between the relative activity (%) of the coenzyme-binding glucose dehydrogenase and the pH, in Example 3 (3.2). Symbols show measured values and types of buffer solutions, which are □: citric acid-sodium phosphate buffer (pH4.6 to 6.2), ♦: potassium phosphate buffer (pH6.8 to 7.2), ◯: Tris-HCl buffer (pH7.8 to 8.6) and ▴: glycine-sodium hydroxide (pH9.2 to 9.5). The optimum pH of the enzyme was 7.0 to 9.0.
  • FIG. 2 shows a graph representing the relationship between the residual activity (%) of the coenzyme-binding glucose dehydrogenase and the pH, in Example 3 (3.3). Symbols show measured values and types of buffer solutions, which are □: citric acid-sodium phosphate buffer (pH3.2 to 6.4), ♦: potassium phosphate buffer (pH6.3 to 6.9), ◯: Tris-HCl buffer (pH7.3 to 8.6) and ▴: glycine-sodium hydroxide (pH9.1 to 11.4). The stable pH of the enzyme was 4.5 to 8.5.
  • FIG. 3 shows a graph representing the relationship between the relative activity (%) of the coenzyme-binding glucose dehydrogenase and the temperature, in Example, 3 (3.4). The optimum temperature of the enzyme was approximately 55° C.
  • FIG. 4 shows a graph representing the relationship between the residual activity (%) of the coenzyme-binding glucose dehydrogenase in Example 3 (3.5) and the treatment temperature. The enzyme was revealed to be stable at 50° C. or below.
  • FIG. 5 shows a calibration curve for quantifying the glucose in Example 4, which indicates the change in DCIP absorption vs the glucose level.
  • FIG. 6 shows a calibration curve for a glucose measurement using a coenzyme-binding glucose dehydrogenase-immobilizing electrode in Example 5. Symbols represent the conditions under: x: argon saturation, Δ: oxygen saturation and ◯: air saturation.
  • BEST MODE FOR CARRYING OUT THE INVENTION
  • An inventive coenzyme-binding glucose dehydrogenase may for example be an enzyme classified as EC 1.1.99, preferably EC 1.1.99.10, EC 1.1.99.13 or EC 1.1.99.17, and is a coenzyme-binding enzyme, preferably a soluble coenzyme-binding enzyme. That is, it is an enzyme capable of being obtained in the state of an aqueous solution without using any surfactant in a step of extraction/purification of the enzyme. As used herein, a coenzyme may be any flavin compound, such as flavin adenine dinucleotide, flavin mononucleotide and the like.
  • The inventive coenzyme-binding glucose dehydrogenase may be a glucose dehydrogenase to which a coenzyme is bound always over the period of the catalytic reaction. The coenzyme-binding glucose dehydrogenase has at least the following characteristics; that is a physicochemical property for catalyzing a reaction for oxidizing glucose in the presence of an electron acceptor, especially for catalyzing a reaction for oxidizing a hydroxyl group in the 1st-position of the glucose. In addition, the coenzyme-binding glucose dehydrogenase has a low activity on maltose, which is at a level for example of 5% or below, preferably 3% or below. Moreover, the enzymatic activity of the coenzyme-binding glucose dehydrogenase is inhibited by 50% or more at 5 mM of 1,10-phenanthroline, preferably by 50% or more at 2 mM as a final concentration of 1,10-phenanthroline, more preferably by 50% or more at 1 mM of 1,10-phenanthroline, especially by 60% or more at 1 mM of 1,10-phenanthroline. The coenzyme-binding glucose dehydrogenase preserves its residual enzymatic activity at a level as high as 85% or more even after a heat treatment for 15 minutes at 50° C. in the presence of 50 mM sodium citrate buffer solution (pH5.5). Moreover, the invention relates to coenzyme-binding glucose dehydrogenase having the physicochemical characteristics described above; or an amino acid sequence encoding the physicochemical characteristics, wherein the amino acid sequence is a protein or a salt as follows: the amino acid sequence encoding the protein or the salt contains a mutation resulting from a deletion, substitution or addition of one or more amino acid residues in the sequence, and such the resultant protein and the salt are biologically active and stable, with respect to the protein or its salt having the activity substantially equivalent to that of the coenzyme-binding glucose dehydrogenase.
  • The protein or its salt, which are the inventive coenzyme-binding glucose dehydrogenase, is preferably one derived from a microorganism having the physicochemical characteristics described above. A microorganism from which the inventive coenzyme-binding glucose dehydrogenase is derived and a microorganism having an ability of producing the inventive coenzyme-binding glucose dehydrogenase may for example be those classified into prokaryotic microorganisms such as genus Archangium, genus Arcaeoglobus, genus Arsenophonus, genus Ahrensia, genus Aureobacterium, genus Aerococcus, genus Aeropyrum, genus Aeromicrobium, genus Aeromonas, genus Aquifex, genus Aquaspirillum, genus Aquabacter, genus Aquabacterium, genus Aquamicrobium, genus Actinolloteichus, genus Actinokineospora, genus Actinocorallia, genus Actinosynnema, genus Actinosporangium, genus Actinobaculum, genus Actinobacilus, genus Actinopycnidium, genus Actinobispora, genus Actinoplanes, genus Actinopolyspora, genus Actinopolymorpha, genus Actinomyces, genus Actinomadura, genus Acrocarpospora, genus Agrococcus, genus Agrobacterium, genus Agromyces, genus Agromatium, genus Agromonas, genus Achromobacter, genus Acholeplasma, genus Asaia, genus Acidianus, genus Acidispaera, genus Acidiphilium, genus Acidimicrobium, genus Acidilobus, genus Acidaminococcus, genus Acidaminobacter, genus Acidithiobacillus, genus Agitococcus, genus Acidothermus, genus Acidocella, genus Acidobacterium, genus Acidovorax, genus Acidomonas, genus Acinetobacter, genus Asiticcacaulis, genus Asteroleplasma, genus Acetitomaculum, genus Acetivibrio, genus Acetoanaerobium, genus Acetogenium, genus Acetothermus, genus Acetonema, genus Acetobacter, genus Acetobacterium, genus Acetohalobium, genus Acetofilamentum, genus Acetomicrobium, genus Azoarcus, genus Azospira, genus Azospirillum, genus Azotobacter, genus Azonexus, genus Azovibrio, genus Azomonas, genus Azomonotrichon, genus Azorhizobium, genus Azorhizophilus, genus Atopobacter, genus Atopobium, genus Anaplasma, genus Aneurinibacillus, genus Anaeroarcus, genus Anaerococcus, genus Anaerosinus, genus Anaerobacter, genus Anaerobaculum, genus Anaerobispirillum, genus Anaerovibrio, genus Anaerofilum, genus Anaeroplasma, genus Anaerobranca, genus Anaerovorax, genus Anaeromusa, genus Anaerorhabdus, genus Anoxybacillus, genus Abiotrophia, genus Afipia, genus Amaricoccus, genus Amycolata, genus Amycolatopsis, genus Aminobacter, genus Aminobacterium, genus Aminomonas, genus Amoebobacter, genus Ammoniphilus, genus Ammonifex, genus Amorphosphorangium, genus Arachnia, genus Alysiella, genus Alicyclobacillus, genus Alishewanella, genus Alcanivorax, genus Arcanobacterium, genus Alcaligenes, genus Alkalibacterium, genus Alkaliphilus, genus Arcobacter, genus Arthrobacter, genus Alterococcus, genus Alteromonas, genus Albibacter, genus Alloiococcus, genus Allochromatium, genus Arhodomonas, genus Allomonas, genus Allorhizobium, genus Anacalochloris, genus Anacalomicrobium, genus Angiococcus, genus Angulomicrobium, genus Ancylobacter, genus Antarctobacter, genus Amphibacillus, genus Ampullariella, genus Ignavigranum, genus Idiomarina, genus Isochromatium, genus Isosphaera, genus Ideonella, genus Ilyobacter, genus Intrasporagium, genus Weeksella, genus Wigglesworthia, genus Williamsia, genus Wolinella, genus wolbachia, genus Ureplasma, genus Ureibacillus, Eikenella, genus Ehrlichia, genus Exiguobacterium, genus Excellospora, genus Ectothiorhodospira, genus Aegyptianella, genus Eggerthella, genus Escherichia, genus Edwardsiella, genus Ewingella, genus Eperythrozonn, genus Erysipelothrix, genus Erythrobacter, genus Erythromicrobium, genus Erythromonas, genus Elytrosporangium, genus Yersinia, genus Erwinia, genus Eremococcus, genus Ensifer, genus Enterococcus, genus Enterobacter, genus Entomoplasma, genus Enhydrobacter, genus Empedobacter, Oenococcus, genus Oerskovia, genus Oceanimonas, genus Oceanospirillum, genus Oxalobacater, genus Oxalophagus, genus Oxobacter, genus Octadecabacter, genus Ochrobactrum, genus Oscillochloris, genus Oscillospira, genus Obesumbacterium, genus Orientia, genus Oligella, genus Oligotropha, genus Oribaculum, genus Ornithinicoccus, genus Ornithinimicrobium, genus Ornithobacterium, genus Orenia, genus Gardnerella, genus Carnimonas, genus Carnobacterium, genus Couchioplanes, genus Cowdria, genus Caulobacter, genus Caseobacter, genus Catenibacterium, genus Catenuloplanes, genus Catenococcus, genus Catellatospora, genus Catonella, genus Capsularis, genus Capnocytophaga, genus Gallionella, genus Carvophanon, genus Gallicola, genus Calymmatobacterium, genus Cardiobacterium, genus Caldicellulosiruptor, genus Caldivirga, genus Calderobacterium, genus Carboxydibrachium, genus Carboxydothermus, genus Carbophilus, genus Caloramator, genus Xanthobacter, Xanthomonas, genus Xylella, genus Xylophilus, genus Xenorhabdus, genus Kitasatoa, genus Kirasatospora, genus Chitinophaga, genus Kytococcus, genus Kineococcus, genus Kineosporia, genus Quinella, genus Kibdelosporangium, genus Campylobacter, genus Kingella, genus Kutzneria, genus Cupriavidus, genus Craurococcus, genus Glaciecola, genus Gracilibacillus, genus Granulicatella, genus Grahamella, genus Clavibacter, genus Chlamydia, genus Chlamydophila, genus Cryobacterium, genus Glycomyces, genus Chrysiogenes, genus Cristispira, genus Chryseobacterium, genus Chryseomonas, genus Crinalium, genus Cryptosporangium, genus Cryprobacterium, genus Kluyvera, genus Kribbella, genus Gluconacetobacter, genus Gluconobacter, genus Kurthia, genus Curtobacterium, genus Crenothrix, genus Klebsiella, genus Clevelandina, genus Crossiella, genus Clostridium, genus Clobicatella, genus Chromatium, genus Chromobacterium, genus Chromohalobacter, genus Chloronema, genus Chrorobium, genus Chloroflexus, genus Chloroherpeton, genus Caedibacter, genus Ketogulonicigenium, genus Gemmata, genus Gemmiger, genus Gemella, genus Gemmobacter, genus Chelatococcus, genus Chelatobacter, genus Gelidibacter, genus Coenonia, genus Coxiella, genus Kocuria, genus Koserella, genus Coprococcus, genus Coprothermobacter, genus Coprobacillus, genus Comamonas, genus Coriobacterium, genus Corynebacterium, genus Collinsella, genus Colwellia, genus Gordonia, genus Conglomeromonas, genus Chondromyces, genus Thermaerobacter, genus Thermus, genus Thermacetogenium, genus Thermanaerovibrio, genus Thermicanus, genus Thermithiobacillus, genus Thermoactinomyces, genus Thermoanaerobacter, genus Thermoanaerobacterium, genus Thermoanaerobium, genus Thermocladium, genus Thermocrispum, genus Thermocrinis, genus Thermochromatium, genus Thermococcus, genus Thermosipho, genus Thermosyntropha, genus Thermosphaera, genus Thermothrix, genus Thermodesulfobacterium, genus Thermodesulfovibrio, genus Thermodesulforhabdus, genus Thermoterrabacterium, genus Thermotoga, genus Thermonema, genus Thermohydrogenium, genus Thermobacteroides, genus Thermobacillus, genus Thermohalobacter, genus Thermobispora, genus Thermobifida, genus Thermofilum, genus Thermobranchium, genus Thermoplasma, genus Thermoproteus, genus Thermomicrobium, genus Thermomonospora, genus Thermoleophilum, genus Cytophaga, genus Zymobacter, genus Zymophilus, genus Zymomonas, genus Sagittula, genus Saccharococcus, genus Saccharothrix, genus Saccharobacter, genus Saccharopolyspora, genus Saccharomonospora, genus Zavarzinia, genus Subtercola, genus Saprospira, genus Samsonia, genus Salinicoccus, genus Salinivibrio, genus Salibacillus, genus Sarcobium, genus Sarcina, genus Salmonella, genus Salegentibacter, genus Sanguibacter, genus Sandaracinobater, genus Dyadobacter, genus Dialister, genus Dietzia, genus Shewanella, genus Geothrix, genus Geodermatophilus, genus Geotoga, genus Geobacter, genus Geobacillus, genus Geovibrio, genus Dictyoglomus, genus Cycloclasticus, genus Psychroserpens, genus Psychrobacter, genus Cyclobacterium, genus Psychroflexus, genus Psychromonas, genus Sigella, genus Dichelobacter, genus Dichoromicrobium, genus Dysgonomonas, genus Cystobacter, genus Citrobacter, genus Synergistes, genus Sinorhizobium, genus Diplocalyx, genus Simkania, genus Simonsiella, genus Janibacter, genus Janthinobacterium, genus Pseudaminobacter, genus Pseudoamyclata, genus Pseudoalteromonas, genus Pseudoxanthomonas, genus Pseudocaedibacter, genus Pseudonocardia, genus Pseudobutyrivibrio, genus Pseudomonas, genus Pseudoramibacter, genus Schwartzia, genus Jonesia, genus Johnsonella, genus Silicibacter, genus Syntrophus, genus Syntrophococcus, genus Syntrophothermus, genus Syntrophosphora, genus Syntrophobacter, genus Syntrophobotulus, genus Syntrophomonas, genus Symbiotes, genus Symbiobacterium, genus Zoogloea, genus Duganella, genus Schineria, genus Succiniclasticum, genus Succinispira, genus Succinivibrio, genus Succinimonas, genus Skermania, genus Skermanella, genus Starkeya, genus Stappia, genus Staphylococcus, genus Staphylothermus, genus Staleya, genus Stygiolobus, genus Stibiobacter, genus Stigmatella, genus Stetteria, genus Stenotrophomonas, genus Stella, genus Suttrella, genus Suttonella, genus Stomatococcus, genus Streptoalloteichus, genus Streptococcus, genus Streptosporangium, genus Streptoverticillium, genus Streptobacillus, genus Streptomyces, genus Streptomonospora, genus Spirillum, genus Spirilliplanes, genus Spirillospora, genus Spirosoma, genus Spiroplasma, genus Spirochaeta, genus Sphingobacterium, genus Sphingobium, genus Sphingopyxis, genus Sphaerotilus, genus Spaerobacter, genus Sphingomonas, genus Sporichthya, genus Sporocytophaga, genus Sporosarcina, genus Sporotomaculum, genus Sporobacter, genus Sporobacterium, genus Sporohalobacter, genus Sporomusa, genus Sporolactobacillus, genus Smithella, genus Slackia, genus Sulfitobacter, genus Sulfobacillus, genus Sulfophobococcus, genus Sulfolobus, genus Sulfurisphaera, genus Sulfurococcus, genus Sulforospirillum, genus Cedecea, genus Setobacterium, genus Sebaldella, genus Serratia, genus Seliberia, genus Cellvibrio, genus Cerpula, genus Serpulina, genus Serpens, genus Cellulosimicrobium, genus Cellulophaga, genus Cellulomonas, genus Selenihalanaerobacter, genus Selenomonas, genus Centipeda, genus Sodalis, genus Zobellia, genus Solobacterium, genus Thauera, genus Dactylosporangium, genus Tatumella, genus Tatlockia, genus Thalassomonas, genus Thialkalicoccus, genus Thialkalivibrio, genus Thialkalimicrobium, genus Thiocapsa, genus Thiococcus, genus Thiodictyon, genus Thiocystis, genus Thiospira, genus Thiospirillum, genus Thiosphaera, genus Thiothrix, genus Thiobacterium, genus Thiobacillus, genus Thiohalocapsa, genus Thioflavicoccus, genus Thiovulum, genus Thioploca, genus Thiopedia, genus Thiomargarita, genus Thiomicrospira, genus Thiomonas, genus Thiolamprovum, genus Thiorhodococcus, genus Thiorhodospira, genus Thiorhodovibrio, genus Tissierella, genus Chania, genus Tindallia, genus Tsukamurella, genus Turicella, genus Deinococcus, genus Deinobacter, genus Taylorella, genus Tectibacter, genus Dechlorosoma, genus Dechloromonas, genus Tessaracoccus, genus Desulfacinum, genus Desulfitobacterium, genus Desulfocapsa, genus Desulfococcus, genus Desulfosarcina, genus Desulfospira, genus Desulfosporosinus, genus Desulfocella, genus Desulfotalea, genus Desulfotignum, genus Desulfotomaculum, genus Desulfonatronum, genus Desulfonatronovibrio, genus Desulfonispora, genus Desulfonema, genus Desulfovirga, genus Desufobacter, genus Desulfobacterium, genus Desulfobacula, genus Desulfobacca, genus Desulfobulbus, genus Desulfohalobium, genus Desulfovibrio, genus Desulfofustis, genus Desulfofaba, genus Desulfofrigus, genus Desulfomicrobium, genus Desulfomonas, genus Desulfomonile, genus Desulforhabdus, genus Desulforhopalus, genus Desulfurella, genus Desulfurococcus, genus Desulfurobacterium, genus Desulfuromusa, genus Desulfuromonas, genus Desulfurolobus, genus Desemzia, genus Dethiosulfovibrio, genus Tetragenococcus, genus Tetrasphaera, genus Denitrobacterium, genus Denitrovibrio, genus Dehalobacter, genus Tepidimonas, genus Deferribacter, genus Defluvibacter, genus Devosia, genus Demetria, genus Terracoccus, genus Terrabacter, genus Derxia, genus Delftia, genus Dermacoccus, genus Dermatophilus, genus Dermabacter, genus Telluria, genus Deleya, genus Dendrosporobacter, genus Toxothrix, genus Trabulsiella, genus Trichlorobacter, genus trichococcus, genus Tlumonas, genus Treponema, genus Dolosigranulum, genus Dolosicoccus, genus Tropheryma, genus Neisseria, genus Natrialba, genus Natrinema, genus Natroniella, genus Natronincola, genus Natronococcus, genus Natronobacterium, genus Natronomonas, genus Natronorubrum, genus Nannocystis, genus Nitrococcus, genus Nitrospina, genus Nitrospira, genus Nitrosococcus, genus Nitrosospira, genus Nitrosomonas, genus Nitorosolobus, genus Nitrobacter, genus Neochlamydia, genus Neorickettsia, genus Nesterenkonia, genus Nevskia, genus Neptunomonas, genus Nocardia, genus Nocardioides, genus Nocardiopsis, genus Nonomuraea, genus Novosphingobium, genus Virgibacillus, genus Hydrogenobacter, genus Hydrogenovibrio, genus Hydrogenophaga, genus Hydrogenophilus, genus Hyperthermus, genus Hyphomicrobium, genus Hyphomonas, genus Paucimonas, genus Bacterionema, genus Bacteriovorax, genus Bacteroides, genus Bactoderma, genus Vagococcus, genus Pasteuria, genus Pasteurella, genus Bacillus, genus Papillibacter, genus Hafnia, genus Hahella, genus Paracraurococcus, genus Parachlamydia, genus Paracoccus, genus Halanaerobacter, genus Halanaerobium, genus Paralactobacillus, genus Variovorax, genus Haliscomenobacter, genus Bartonella, genus Balneatrix, genus Palaeococcus, genus Hallella, genus Haloarcula, genus Haloincola, genus Halochromatium, genus Halococcus, genus Halothermothrix, genus Halogeometricum, genus Halospirulina, genus Halocella, genus Halothiobacillus, genus Haloterrigena, genus Halonatronum, genus Halobaculum, genus Halobacterium, genus Halobacteroides, genus Halobacillus, genus Halobvibrio, genus Haloferax, genus Halomethanococcus, genus Halomonas, genus Halorhabdus, genus Halorubrum, genus Halorubrobacterium, genus Halorhodospira, genus Pantoea, genus Pandoraea, genus Vampirovibrio, genus Picrophilus, genus Piscirickettsia, genus Hippea, genus Vitreoscilla, genus Bifidobacterium, genus Vibrio, genus Hymenobacter, genus Pimelobacter, genus Pilimelia, genus Hirschia, genus Pirella, genus Pirellula, genus Pyrococcus, genus Pyrodictium, genus Pillotina, genus Pyrobaculum, genus Bilophila, genus Pyrolobus, genus Faenia, genus Facklamia, genus Phascolarctobacterium, genus Falcivibrio, genus Fundibacter, genus Finegoldia, genus Fibrobacter, genus Filibacter, genus Filifactor, genus Phyllobacterium, genus Filobacillus, genus Filomicrobium, genus Phaeospirillum, genus Phenylobacterium, genus Ferriacterium, genus Ferrimonas, genus Fervidobacterium, genus Ferroglobus, genus Ferroplasma, genus Phocoenobacter, genus Photobactrium, genus Photorhabdus, genus Formivibrio, genus Fusobacterium, genus Buttiauxella, genus Butyrivibrio, genus Bdellovibrio, genus Budvicia, genus Phennigia, genus Buchnera, genus Fusibacter, genus Prauserella, genus Pragia, genus Bracyspira, genus Bracybacterium, genus Bracymonas, genus Blastochloris, genus Blastococcus, genus Blastobacter, genus Blastomonas, genus Blattabacterium, genus Bradyrhizobium, genus Frateuria, genus Branhamella, genus Planococcus, genus Planotetraspora, genus Planobispora, genus Planopolyspora, genus Planomicrobium, genus Planomonospora, genus Flavimonas, genus Flavobacterium, genus Flammeovirga, genus Frankia, genus Planctomyces, genus Francisella, genus Friedmanniella, genus Frigoribacterium, genus Fluoribacter, genus Burkholderia, genus Brucella, genus Bulleidia, genus Flexistipes, genus Flexithrix, genus Flexibacter, genus Flectobacillus, genus Plesiomonas, genus Brenneria, genus Brevundimonas, genus Brevinema, genus Brevibacterium, genus Brevibacillus, genus Prevotella, genus Prochlorococcus, genus Prochlorothrix, genus Prochloron, genus Brochothrix, genus Prosthecochloris, genus Prosthecobacter, genus Prosthecomicrobium, genus Proteus, genus Protomonas, genus Propionigenium, genus Propionispira, genus Propionispora, genus Propionibacter, genus Propionibacterium, genus Propionivibrio, genus Propioniferax, genus Providencia, genus Promicromonospora, genus Prolinoborus, genus Beijejrinckia, genus Veillonella, genus Beutenbergia, genus Beggiatoa, genus Pectinatus, genus Pectobacterium, genus Pediococcus, genus Pedobacter, genus Pedomicrobium, genus Petrotoga, genus Paenibacillus, genus Beneckea, genus Peptococcus, genus Peptostreptococcus, genus Peptoniphilus, genus Haemobartonella, genus Haemophilus, genus Heliothrix, genus Heliobacterium, genus Heliobacillus, genus Heliophilum, genus Heliorestis, genus Helicobacter, genus Pelistega, genus Pelczaria, genus Bergeyella, genus Helcococcus, genus Verrucosispora, genus Verrucomicrobium, genus Persicobacter, genus Herbaspirillum, genus Herbidospora, genus Herpetosiphon, genus Pelodictyon, genus Pelospora, genus Pelobacter, genus Vogesella, genus Bogoriella, genus Bosea, genus Polaribacter, genus Polaromonas, genus Hollandina, genus Polyangium, genus Polynucleobacter, genus Volcaniella, genus Bordetella, genus Holdemania, genus Porphyrobacter, genus Porphyromonas, genus Borrelia, genus Holospora, genus Holophaga, genus Hongia, genus Meiothermus, genus Mycobacterium, genus Mycoplasma, genus Mycoplana, genus Mycetocola, genus Myroides, genus Magnetospirillum, genus Macrococcus, genus Macromonas, genus Massilia, genus Maricaulis, genus Marichromatium, genus Marinococcus, genus Marinitoga, genus Marinilabilia, genus Marinospirillum, genus Marinobacter, genus Marinobacterium, genus Marinomonas, genus Marmoricola, genus Malonomonas, genus Mannheimia, genus Micavibrio, genus Myxococcus, genus Microellobosporia, genus Micrococcus, genus Microcyclus, genus Microcystis, genus Microscilla, genus Microsphaera, genus Microtetraspora, genus Microvirgula, genus Microbacterium, genus Microbulbifer, genus Microbispora, genus Micropruina, genus Micropolyspora, genus Micromonas, genus Micromonospora, genus Microlunatus, genus Mitsuokella, genus Megasphaera, genus Megamonas, genus Mesophilobacter, genus Mesoplasma, genus Mesorhizobium, genus Methanimicrococcus, genus Methanocalculus, genus Methanoculleus, genus Methanogenium, genus Methanocorpusculum, genus Methanococcoides, genus Methanococcus, genus Methanothermus, genus Methanothermobacter, genus Methanosaeta, genus Methanosarcina, genus Methanospirillum, genus Methanosphaera, genus Methanothrix, genus Methanobacterium, genus Methanohalobium, genus Methanohalophilus, genus Methanopyrus, genus Methanofollis, genus Methanoplanus, genus Methanoburevibacter, genus Methanomicrobium, genus Methanolacinia, genus Methanolobus, genus Methallosphaera, genus Methylarcula, genus Methylocaldum, genus Methylococcus, genus Methylcarcina, genus Methylocystis, genus Methylosinus, genus Methysphaera, genus Methylcella, genus Methylbacter, genus Methylbacterium, genus Methylobacillus, genus Methylopila, genus Methylophaga, genus Methylpholus, genus Methylovorus, genus Methylmicrobium, genus Methylomonas, genus Methylorhabdus, genus Meniscus, genus Melittangium, genus Melissococcus, genus Moellerella, genus Moorella, genus Mogibacterium, genus Modestobacter, genus Mobiluncus, genus Moraxella, genus Morganella, genus Mortiella, genus Morococcus, genus Eubacterium, genus Iodobacter, genus Yokenella, genus Rahnella, genus Raoultella, genus Lactococcus, genus Lactosphaera, genus Lactobacillus, genus Lachnospira, genus Rathayibacter, genus Rhabdochromatium, genus Labrys, genus Ralstonia, genus Rarobacter, genus Lamprocystis, genus Lamprobacter, genus Lampropedia, genus Riemerella, genus Rickettsia, genus Rickettsiella, genus Rikenella, genus Listeria, genus Listonella, genus Lysobacter, genus Rhizobacter, genus Rhizobium, genus Rhizomonas, genus Lyticum, genus Limnobacter, genus Lewinella, genus Ruegeria, genus Rugamonas, genus Lucibacterium, genus Luteimonas, genus Luteococcus, genus Runella, genus Rubrivivax, genus Rubrimonas, genus Rubrobacter, genus Ruminococcus, genus Ruminobacter, genus Leifsonia, genus Leclercia, genus Lechevalieria, genus Legionella, genus Renibacterium, genus Levinea, genus Leptospira, genus Leptospirillum, genus Leptothrix, genus Leptotrichia, genus Leptonema, genus Leminorella, genus Lentzea, genus Leucothrix, genus Leuconostoc, genus Leucobacter, genus Lawsonia, genus Lautropia, genus Lochalimaea, genus Roseateles, genus Roseinatronobacter, genus Roseibium, genus Roseivivax, genus Roseococcus, genus Roseospira, genus Roseospirillum, genus Roseobacter, genus Roseovarius, genus Roseomonase, genus Roseburia, genus Rhodanobacter, genus Rothia, genus Rhodococcus, genus Rhodothermus, genus Rhodocyclus, genus Rhodocista, genus Rhodopseudomonas, genus Rhodospira, genus Rhodospirillum, genus Rhodothalassium, genus Rhodobaca, genus Rhodobacter, genus Rhodobium, genus Rhodovibrio, genus Rhodopila, genus Rhodoferax, genus Rhodoplanes, genus Rhodovulum, genus Rhodomicrobium, genus Lonepinella, genus Weissella, genus Waddlia and the like.
  • Those which can also be exemplified are eukaryotic microorganisms such as genus Issatchenkia, Candida, genus Cryptococcus, genus Kluyverintces, genus Kloeckera, genus Saccharomycodes, genus Saccharomyces, genus Zygosaccharomyces, genus Shizosaccharomyces, genus Sirobasidium, genus Strigmatomyces, genus Sporidobolus, genus Sporobolomyces, genus Dekkera, genus Debaryomyces, genus Trichosporon, genus Trigonopsis, genus Torulaspora, genus Tremella, genus Nadsonia, genus Nematospora, genus Hanseniaspora, genus Pichia, genus Fibulobasidium, genus Filobasidium, genus Filobasidiella, genus Bullera, genus Brettanomyces, genus Holtermannia, genus Malassezia, genus Metschnikowia, genus Lipomyces, genus Leucosporidium, genus Rhodosporidium, genus Rhodotorula, genus Acaulopage, genus Aquamortierella, genus Asellaria, genus Amoebidium, genus Amoeophilus, genus Arundinula, genus Utharomyces, genus Echinosporangium, genus Enterobryus, genus Endogone, genus Entomophthora, genus Kickxella, genus Genistellospora, genus Choanephora, genus Coemansia, genus Cochlonema, genus Conidiobolus, genus Saksenaea, genus Thamnidium, genus Thamnocephalis, genus Dispira, genus Dimargaris, genus Syncephalastrum, genus Syncephalis, genus Zoopage, genus Sclerocystis, genus Smittium, genus Basidiobolus, genus Parataeniella, genus Paramoebidium, genus Palavascia, genus Harpella, genus Piptocephalis, genus Pilobolus, genus Phycomyces, genus Blakeslea, genus Hesseltinella, genus Helicocephalum, genus Mycotypha, genus Radiomyces, genus Legeriomyces, genus Rhopalomyces, genus Acrasis, genus Acytostelium, genus Arcyria, genus Echinostelium, genus Echinosteliopsis, genus Oligonema, genus Cavostelium, genus Guttulinopsis, genus Clastoderma, genus Cribraria, genus Coenonia, genus Copromyxa, genus Comatricha, genus Colloderma, genus Dianema, genus Dictyostelium, genus Didymium, genus Diderma, genus Stemonitis, genus Thraustochytrium, genus Ceratiomyxa, genus Ceratiomyxella, genus Trichia, genus Physarum, genus Plasmodiophrora, genus Fuligo, genus Bursulla, genus Prorostelium, genus Protosporangium, genus Hemitrichia, genus Perichaena, genus Polysphondylium, genus Polymyxa, genus Labyrinthula, genus Lamproderma, genus Lycogala, genus Licea, genus Wardmyces, genus Actinopelte, genus Asterosporium, genus Arthrinium, genus Alternaria, genus Oidium, genus Clabosporium, genus Cladobotryum, genus Graphium, genus Colletotrichum, genus Sclerotium, genus Stagonospora, genus Stibella, genus Tubercularia, genus Bactridium, genus Pycnothrium, genus Phaeoisaria, genus Pestalozziella, genus Rhizoctonia, genus Rhinocladiella, genus Leptothyrium, genus Achlyogeton, genus Anisolpidium, genus Albugo, genus Ectrogella, genus Olipidium, genus Olpidiopsis, genus Catenaria, genus Chytridium, genus Cladochytrium, genus Coelomomyces, genus Gonapodya, genus Saprolegnia, genus Sirolpidium, genus Synchytrium, genus Haliphthoros, genus Harpochytrium, genus Pythium, genus Hyphochytrium, genus Physoderma, genus Phlyctidium, genus Blastocladia, genus Peronospora, genus Peronophythora, genus Micormycopsis, genus Megachytrium, genus Monoblepharis, genus Lagenidium, genus Rhizidiomyces, genus Rhizidium, genus Rhipidium, genus Leptomitus, genus Leptolegniella, genus Acremonium, genus Aspergillus, genus Absidia, genus Arachniotus, genus Arthrobotrys, genus Ulocladium, genus Echinobotryum, genus Exophiala, genus Epicoccum, genus Oidiodendron, genus Oedocephalum, genus Aureobasidium, genus Curvularia, genus Candelabrella, genus Cunninghamella, genus Gymnoascus, genus Cladosporium, genus Graphium, genus Gliocladium, genus Chrysosporium, genus Chromelosporium, genus Geotrichum, genus Geomyces, genus Chaetomium, genus Geniculifera, genus Gonatobotrysm, genus Coniothyrium, genus Circinella, genus Zygorhynchus, genus Diplodia, genus Cylindrocarpon, genus Scopulariopsis, genus Stachybotrys, genus Stemphylium, genus Sporothrix, genus Sepedonium, genus Dactylella, genus Talaromyces, genus Dratomyces, genus Trichurus, genus Trichocladium, genus Trichothecium, genus Trichoderma, genus Trichophyton, genus Nigrospora, genus Verticicladiella, genus Verticillium, genus Paecilomyces, genus Pithomyces, genus Bipolaris, genus Pyrenochaeta, genus Phialocephala, genus Phialophora, genus Phoma, genus Fusarium, genus Pestalotiopsis, genus Penicillium, genus Botrytis, genus Microsporum, genus Myrothecium, genus Mucor, genus Memnoniella, genus Monacrosporium, genus Monilia, genus Mortierella, genus Eupenicillium, genus Eurotium, genus Rhizopus, genus Leptographium, genus Robillarda, genus Austroboletus, genus Auricularia, genus Auriscalpium, genus Agaricus, genus Agrocybe, genus Asterophona, genus Astraeus, genus Aseroe, genus Anellaria, genus Amauroderma, genus Amanita, genus Armillaria, genus Armillariella, genus Alcuria, genus Ischnoderma, genus Inocybe, genus Inonotus, genus Ileodictyon, genus Wynnea, genus Verpa, genus Volvariella, genus Urnula, genus Echinodontium, genus Exidia, genus Elfvingia, genus Oudemansiella, genus Omphalina, genus Onnia, genus Catathelasma, genus Ganoderma, genus Camarophyllus, genus Chalciporus, genus Galerina, genus Calocera, genus Calostoma, genus Cantharellus, genus Cantharellula, genus Cyathus, genus Cyclomyces, genus Cystoderma, genus Cyptotrama, genus Cymatoderma, genus Gymnopilus, genus Kuehneromyces, genus Gyrodon, genus Gyroporus, genus Gyromitra, genus Guepinia, genus Xanthoconium, genus Xylaria, genus Xerocomus, genus Xeromphalina, genus Cudonia, genus Clavatia, genus Clavaria, genus Clavariadelphus, genus Clavicorona, genus Clavulina, genus Clavulinopsis, genus Craterellus, genus Clathrus, genus Clitocybe, genus Clitopilus, genus Crinipellis, genus Grifola, genus Cryptoderma, genus Cryptoporus, genus Crucibulum, genus Creolophus, genus Crepidotus, genus Chroogomphus, genus Chlorosplenium, genus Geastrum, genus Geolossum, genus Cotylidia, genus Conocybe, genus Kobayashia, genus Coprinus, genus Gomphidius, genus Gomphus, genus Coriolus, genus Cordyceps, genus Cortinarius, genus Coltricia, genus Collybia, genus Sarcoscypha, genus Sarcodon, genus Sarcodontia, genus Suillus, genus Schizophyllum, genus Squamanita, genus Scutellinia, genus Scleroderma, genus Stereum, genus Strobilomyces, genus Stropharia, genus Spathularia, genus Sparassis, genus Daedaleopsis, genus Dacryomyces, genus Daldinia, genus Dictyophora, genus Tylopilus, genus Tyromyces, genus Descolea, genus Thelephora, genus Tulostoma, genus Trametes, genus Trichoglossum, genus Torichocoma, genus Tricoloma, genus Tricholomopsis, genus Tremella, genus Tremellodon, genus Naematoloma, genus Nidula, genus Neobulgaria, genus Baeospora, genus Paxillus, genus Battarea, genus Panaeolus, genus Panus, genus Panellus, genus Bankera, genus Hygrocybe, genus Hygrophorus, genus Hygrophoropsis, genus Bisporella, genus Pisolithus, genus Hydnum, genus Hydnellum, genus Hypsizygus, genus Piptoporus, genus Hypoxylon, genus Hymenochaete, genus Hirschioporus, genus Pyrrhoderma, genus Favolus, genus Phaeolus, genus Phaeolepiota, genus Phallus, genus Fistulina, genus Phyllotopsis, genus Phylloporus, genus Filoboletus, genus Phellinus, genus Fomitopsis, genus Fomes, genus Pholiota, genus Psathyrella, genus Psilocybe, genus Pseudocolus, genus Pseudohiatula, genus Prerula, genus Flammulina, genus Pulveroboletus, genus Bulgaria, genus Pluteus, genus Pleurocybella, genus Pleurotus, genus Plectania, genus Phlogiotis, genus Peziza, genus Penicilliopsis, genus Hebeloma, genus Hericium, genus Helvella, genus Podostroma, genus Polyozellus, genus Polyporus, genus Polyporellus, genus Holtermannia, genus Boibitius, genus Porphyrellus, genus Boletinus, genus Boletellus, genus Boletus, genus Boletopsis, genus Porodisculus, genus Bondarzewia, genus Macrocystidia, genus Macropodia, genus Macrolepiota, genus Marasmius, genus Marasmiellus, genus Microporus, genus Mycena, genus Mitrula, genus Mutinus, genus Melanoleuca, genus Merulius, genus Morchella, genus Laetiporus, genus Lactarius, genus Lasiosphaera, genus Laccaria, genus Ramaria, genus Lampteromyces, genus Lyophyllum, genus Rigidoporus, genus Lycoperdon, genus Rhizina, genus Lysurus, genus Limacella, genus Linder, genus Russula, genus Leucocoprinus, genus Leucopaxillus, genus Leotia, genus Resupinatus, genus Leccinum, genus Lepiota, genus Lepista, genus Lenzites, genus Lentaria, genus Lentinus, genus Lentinula, genus Lentinellus, genus Rozites, genus Rhodocybe, genus Rhodotus, genus Rhodophyllus and the like.
  • A microorganism listed above which has an ability of producing an inventive coenzyme-binding glucose dehydrogenase has been deposited under its accession number to IFO, ATCC and the like, and can be obtained from known distributors and corporations. Such a microorganism may for example be a eukaryotic microorganism, more preferably mycotic microorganism. It is also possible to use the microorganism which is designated as “97508” and was deposited under FERM BP-08578 to International Patent Organism Depositary of National Institute of Advanced Industrial Science and Technology.
  • In one embodiment of the method for producing the inventive coenzyme-binding glucose dehydrogenase, a microorganism having an ability of producing the inventive coenzyme-binding glucose dehydrogenase is cultured in a nutrition medium, in which the coenzyme-binding glucose dehydrogenase is allowed to be produced and accumulated, and then recovered to yield a protein which is the coenzyme-binding glucose dehydrogenase and its salt.
  • The deposited inventive strain FERM BP-08578, a coenzyme-binding glucose dehydrogenase derived therefrom, and a method for obtaining the enzyme are described below.
  • 1. Physicochemical Characteristics of FERM BP-08578-Derived Enzyme
  • (1) Effect: On the basis of the classification by International Union of Biochemistry (IUB), the inventive enzyme corresponds to EC1.1.99.10, and catalyzes the reaction shown below which oxidizes a hydroxyl group in the 1st-position of glucose in the presence of an electron acceptor to yield glucono-δ-lactone.

  • Glucose+Electron acceptor→Glucono-δ-lactone+reduced electron acceptor
  • In the invention, the electron acceptor may for example be phenazine methosulfate, 1-methoxy-5-methylphenazinium methyl sulfate, 2,6-dichlorophenolindophenol, ferricyanides and the like.
  • (2) Substrate specificity: The relative reactivity (substrate specificity) of the inventive enzyme when using D-glucose and other substrates (all at the final concentration of 333 mM except for D-cellobiose at 193 mM, D-trehalose and D-raffinose at 121 mM) by the activity measurement method 1 described below are shown in Table 1. The relative reactivity (substrate specificity) when using D-glucose and maltose at the final concentrations of 550 mM and 100 mM are shown in Table 2. A higher activity was observed on D-glucose, while lower activity were observed on D-mannose, 1,5-anhydro-D-glucitol, D-cellobiose, D-trehalose, maltose, D-galactose, D-glucose-6-phosphate and D-fructose. Almost no activity was observed on L-arabinose, lactose, D-sorbitol, gluconic acid, sucrose, D-mannitol, L-sorbose, D-ribose, L-rhamnose, D-glucose-1-phosphate, D-raffinose, ethanol or glycerol.
  • (3) Optimum pH: pH7.0 to pH9.0.
  • (4) pH for stability: pH4.5 to pH8.5.
    (5) Optimum temperature: Approximately 55° C.
    (6) Thermal stability: Stable at 50° C. or below.
    (7) Molecular weight: About 130 kDa when measured by a gel filtration method, and about 85 kDa when measured by a sodium dodecyl sulfate-polyacrylamide gel electrophoresis.
    (8) Km value: 49.7 mM (D-glucose).
    (9) Isoelectric point: The isoelectric point (pI) of the coenzyme-binding glucose dehydrogenase measured by an isoelectric focusing was about 4.4.
    (10) Inhibitor: When each additive was added at 1 mM as a final concentration to the activity measurement method 1 described below and the activity was measured, an inhibitory effect of each additive was observed when comparing with the control group as shown in Table 3. When adding 1,10-phenanthroline (dissolved in methanol) at each final concentration to the activity measurement method 1 described below, the inhibitory effect shown in Table 4 was observed. The activity of this enzyme was inhibited potently by heavy metal ions (Ag+, Cu2+, Hg2+), and inhibited by 60% or higher by 1,10-phenanthroline, proflavin and Mn2+.
    (11) Coenzyme: Flavin adenine dinucleotide.
  • The amino acid sequence of the coenzyme-binding glucose dehydrogenase and the base sequence of a gene encoding it are also encompassed by the invention.
  • For producing the inventive coenzyme-binding glucose dehydrogenase, a microorganism for producing the coenzyme-binding glucose dehydrogenase may be any microorganism as far as it can produce the inventive coenzyme-binding glucose dehydrogenase, and the enzyme can efficiently be produced by using a microorganism, preferably a eukaryotic microorganism, more preferably a mycotic microorganism. It is especially preferred to use the microorganism which is designated as “97508” and was deposited under FERM BP-08578 to International Patent Organism Depositary of National Institute of Advanced Industrial Science and Technology. The deposited strain was isolated from a soil by Applicants, and has the mycological characteristics as described below. In the invention, any variant of the strain mentioned above may also be employed. Such a variant can be obtained for example by the irradiation with an ultraviolet light or X-ray or the treatment with a chemical modifier (NTG and the like).
  • 2. Mycological Characteristics of FERM BP-08578
  • (1) Morphological characteristics: The morphological profile of the present strain when observed by an optical microscope after allowed to grow on a potato dextrose agar medium is described below. Each mycelium has a width of 2 μm to 4 μm, and has a regular septum. Most of the mycelia grow linearly, and have branches with almost no swollen mycelia being observed. Several mycelia are gathered together to form a mycelial bundle. The mycelial width is almost constant. The surface of a mycelium is smooth and the septum is slightly thick. A crystalloid is formed around the root of the aerial mycelia. No clamp connection is formed. The mycotic body formed in 2-week culture exhibited no formation of any sexual or asexual reproductive organs, and no oidia or thick-walled spores are present.
    (2) Growth condition in various culture media: On all agar plates, each mycelium is in a form of a fluff. The aerial mycelium shade is white. On the potato dextrose agar plate, the backside color is pale orange to orange. The growth magnitude is medium, and a colony after culturing at 25° C. for 1 week has a diameter of 30 mm to 35 mm on the potato dextrose and oatmeal agar plates, and 37 mm to 38 mm on the malt extract agar plate. The production of soluble pigments of a pale yellow color on the potato dextrose agar plate and a slightly reddish to grey-reddish color on the oatmeal agar plate was noted. The mycotic body formed in 2-week culture exhibited no formation of reproductive organs such as a conidiophore, and no exudate was produced.
    (3) Physiological characteristics: The present strain is an aerobic one and has an optimum growth temperature of about 37° C. on the potato dextrose agar plate.
  • 3. Taxonomical Characteristics of FERM BP-08578
  • Based on the characteristics described above, the deposited strain “97508” was characterized with referring to Ainsworth 86 Bisby's Dictionary of the Fungi, 7th edition (Ed. by Hawksworth, Sutton, Ainsworth). As a result of this characterization, the deposited strain was revealed to be a microorganism classified into the genus Aspergillus. Then its genome sequence was subjected to BLAST homology search. An 18S rDNA fragment was amplified using a genome DNA as a template by PCR method, and then sequence of the purified PCR product was analyzed. In order to search for an analogous base sequence through GenBank (GenBank/EMBL/DDBJ international DNA sequence database), BLAST (Altschul et al., 1997) homology search was conducted, and revealed that this deposited strain “97508” is Aspergillus terreus.
  • In one embodiment of the method for producing a coenzyme-binding glucose dehydrogenase according to the invention, the microorganism described above is cultured to allow the coenzyme-binding glucose dehydrogenase to be expressed or produced by the microorganism in internal and/or external of its fungus body.
  • For the culture of the microorganism in the invention, any ordinary culture medium for microorganism may be used. Such medium may include a synthetic or natural medium, as long as it contains suitable amounts of carbon sources, nitrogen sources, inorganic substances and other trace elements required by the microorganism. The carbon sources may be glucose, sucrose, dextrin, starch, glycerin, syrup and the like. The nitrogen sources may be inorganic salts such as ammonium chloride, ammonium nitrate, ammonium sulfate and ammonium phosphate, amino acids such as DL-alanine and L-glutamic acid, as well as nitrogen-containing natural materials such as peptone, meat extract, yeast extract, malt extract, corn steep liquor and the like. The inorganic materials may for example be monosodium phosphate, disodium phosphate, monopotassium phosphate, dipotassium phosphate, magnesium sulfate, ferric chloride and the like.
  • The culture in order to obtain the inventive coenzyme-binding glucose dehydrogenase is conducted preferably in an aerobic condition for example by a shaking or aerating culture at a temperature of 25° C. to 60° C. at a pH of 5 to 8. The culture period ranges preferably from 2 days to 4 days. As a result of such a culture, the coenzyme-binding glucose dehydrogenase can be produced and accumulated in the culture, especially in a culture fluid. By using this culture method, the coenzyme-binding glucose dehydrogenase can be produced by the microorganism and accumulated also internal fungus body. Subsequently, the coenzyme-binding glucose dehydrogenase can be recovered from the culture by means of an ordinary protein purification method. Such a method may be a method comprising incubating the microorganism followed by removing the microorganism for example by a centrifugation to obtain a supernatant, or a method comprising incubating the microorganism, recovering the cultured microorganism from the culture fluid by a centrifugation, crushing the cultured microorganism by a suitable method, and then isolating a supernatant for example by a centrifugation from the pelletized microorganism fluid. The coenzyme-binding glucose dehydrogenase contained in such a supernatant can be purified by a combination of suitable purification procedures such as salting out, solvent sedimentation, dialysis, ion exchange chromatography, hydrophobic adsorption chromatography, gel filtration, affinity chromatography, electrophoresis and the like.
  • In the culture for obtaining the inventive coenzyme-binding glucose dehydrogenase, a solid medium can be also used. The method for such a culture is not limited particularly, and may for example be a static culture, or a dynamic culture involving a continuous agitation of the culture, such as a rotational culture or fluidized bed culture, with a static culture being preferred due to a less expensive investment in equipment. Thereafter, as a method of obtaining the coenzyme-binding glucose dehydrogenase from the culture, an ordinary protein purification method can be adopted. That is, the culture is combined with water or other extraction medium and shaken, made free of any solid components such as bran by means of a centrifugation or filtration, thereby yielding an extract. It is also possible that the coenzyme-binding glucose dehydrogenase accumulated in the fungus bodies can be recovered by grinding the culture residue after obtaining the extract described above together with a an abrasive compound such as a sea sand, followed by adding water to extract the coenzyme-binding glucose dehydrogenase released from the fungus bodies. In order to obtain the entire coenzyme-binding glucose dehydrogenase, the entire culture is ground with an abrasive compound such as a sea sand, followed by adding water to extract both of the coenzyme-binding glucose dehydrogenase released from the fungus bodies and the coenzyme-binding glucose dehydrogenase secreted into the culture all at once. The coenzyme-binding glucose dehydrogenase contained in such a supernatant can be purified by a combination of suitable purification procedures such as salting out, solvent sedimentation, dialysis, ion-exchange chromatography, hydrophobic adsorption chromatography, gel filtration, affinity chromatography, electrophoresis and the like.
  • Alternatively, the inventive coenzyme-binding glucose dehydrogenase may also be a synthetic coenzyme-binding glucose dehydrogenase or a recombinant coenzyme-binding glucose dehydrogenase obtained by a gene engineering technology. Those skilled in the art can obtain the coenzyme-binding glucose dehydrogenase readily based on the disclosure of the protein or its salt derived from the physicochemical characteristics of the inventive coenzyme-binding glucose dehydrogenase. For example, the coenzyme-binding glucose dehydrogenase can be extracted from a microorganism including a fungi or a naturally occurring material such as an animal or plant, or can be obtained synthetically with referring to the amino acid sequence or the base sequence of the gene encoding it. Moreover, it is also possible to produce the coenzyme-binding glucose dehydrogenase industrially using a gene engineering method in which a gene segment of the coenzyme-binding glucose dehydrogenase gene is inserted into a known expression vector such as a commercial expression vector and then the resultant plasmid is used to transform a host such as Escherichia coli to obtain a transformant which is then cultured to obtain a target coenzyme-binding glucose dehydrogenase.
  • For measuring the activity of the inventive enzyme, the enzyme is diluted appropriately to a final concentration of 0.1 to 1 unit/ml. The enzymatic activity unit of the enzyme is the enzymatic activity enabling the oxidation of 1 μmol glucose per minute. The enzymatic activity of the inventive coenzyme-binding glucose dehydrogenase can be measured by the method shown below.
  • (i) Enzymatic Activity Measurement Method 1
  • To a 3-ml quartz cell (light path length: 1 cm), 1.0 ml of 0.1M potassium phosphate buffer (pH7.0), 1.0 ml of 1.0M D-glucose, 0.1 ml of 3 mM 2,6-dichlorophenolindophenol (hereinafter referred to as DCIP), 0.2 ml of 3 mM 1-methoxy-5-methylphenazinium methyl sulfate and 0.65 ml of water are added, which is followed by setting in a thermostat cell holder-mounted spectrophotometer and incubated at 37° C. for 5 minutes and then supplemented with 0.05 ml of the enzyme solution, and then measuring the change in the absorption of DCIP at 600 nm (ΔABS/min). Based on a molar extinction coefficient of DCIP at pH7.0 being regarded as 16.3×103 cm−1M−1 and the enzymatic activity corresponding to the reduction of 1 μmol of DCIP per minute being equivalent to 1 unit of the enzymatic activity, the enzymatic activity was determined from the change in the absorption on the basis of the following equation.

  • Enzymatic activity (unit/ml)=(−ΔABS/16.3)×(3.0/0.05)×Enzyme dilution rate
  • (ii) Enzymatic Activity Measurement Method 2
  • It was carried out that 3.4 μl of 1.0M potassium phosphate buffer (pH7.0), 0.1 ml of 1.0M D-glucose and 86.6 μl of 20 mM DCIP were incubated at 37° C. for 5 minutes, supplemented with 0.01 ml of an enzyme solution, stirred, reacted for 5 minutes, incubated at 100° C. for 3 minutes to quench the reaction. Thereafter, 0.19 ml of 100 mM glycine-sodium buffer (pH13.0), 0.01 ml of 2.0N potassium hydroxide were added, incubated at 37° C. for 10 minutes to convert D-gluconic acid in the solution into D-glucono-δ-lactone, and thereafter combined with 0.39 ml of a 100 mM Tris-HCl buffer (pH7.5) and 0.01 ml of 1.0N hydrochloric acid to achieve a neutral pH. The D-gluconic acid in the solution was quantified using the D-gluconic acid/D-glucono-δ-lactone measurement kit (Boehringer Mannheim). Since the enzymatic activity corresponding to the production of 1 μmol of D-glucono-δ-lactone per minute is equivalent substantially to 1 unit of this enzyme, this enzymatic activity was determined based on the amount of D-glucono-δ-lactone produced.
  • The invention relates to a material production and an analytical application employing an inventive coenzyme-binding glucose dehydrogenase, and also relates to the use in the modification of pharmaceutical or food product materials. In one example, the use is made in a method for eliminating glucose in a sample containing a biological material using the coenzyme-binding glucose dehydrogenase as a reagent, a measurement method as well as in such a reagent or a reagent composition. The use is made also in a method for producing an organic compound using the inventive coenzyme-binding glucose dehydrogenase as well as in a basic ingredient therefor.
  • The inventive coenzyme-binding glucose dehydrogenase is the enzyme that catalyzes a reaction for oxidizing glucose in the presence of an electron acceptor. In the invention, the reaction mentioned above employs the inventive coenzyme-binding glucose dehydrogenase. Such a coenzyme-binding glucose dehydrogenase is not limited particularly, and is preferably a coenzyme-binding glucose dehydrogenase derived from a eukaryotic microorganism producing the coenzyme-binding glucose dehydrogenase, with a coenzyme-binding glucose dehydrogenase derived from a mycotic microorganism being preferred especially.
  • Now the description is made with regard to the application of the coenzyme-binding glucose dehydrogenase obtained according to the invention. Since the coenzyme-binding glucose dehydrogenase is the enzyme that catalyzes a reaction for oxidizing glucose in the presence of an electron acceptor, any application in which the change resulting from such a reaction can be utilized can be mentioned. For example, the coenzyme-binding glucose dehydrogenase can be used in a reagent for measuring or eliminating glucose in a sample containing a biological material. It is also possible to use in medical and clinical fields, and also in the material production and analysis employing the coenzyme-binding glucose dehydrogenase.
  • The inventive biosensor may be any sensor having a reaction layer containing the inventive coenzyme-binding glucose dehydrogenase as an enzyme. For example, the biosensor can be produced in a method wherein an enzymatic reaction layer formed thereon containing a hydrophilic polymer, a redox enzyme and an electron acceptor is brought into contact with an electrode system consisting of an action electrode, a counter electrode and a reference electrode is formed for example by a screen printing on an insulating board. When a substrate-containing sample solution is dropped onto the enzymatic reaction layer in this biosensor, the enzymatic reaction layer is dissolved to effect the reaction between the enzyme and the substrate, thereby reducing the electron acceptor. After completion of the enzymatic reaction, the reduced electron acceptor is oxidized electrochemically, whereupon the biosensor can measure the concentration of the substrate in the sample based on the resultant oxidation current value. Otherwise, a biosensor can be constructed so that the chromogenic intensity or pH change is detected. By using above mentioned biosensors, any of various materials can be measured by selecting the enzyme whose substrate is the target substance. For example, when the inventive coenzyme-binding glucose dehydrogenase is selected as an enzyme, a glucose sensor enabling the measurement of the concentration of glucose in a sample solution can be produced.
  • As the electron acceptor in the biosensor, a chemical substance having an excellent ability of transferring an electron can be employed. Such a chemical substance having an excellent ability of transferring an electron is generally a substance referred to as “electron carrier”, “mediator” or “oxidation/reduction(redox)-mediating agent”, such as the electron transfer and the redox-mediating agent listed in JP-W-2002-526759.
  • In the biosensor, an inexpensive potassium ferricyanide (potassium hexacyanoferrate (III)) is generally employed as an electron acceptor, and usually used at a final concentration of 1 mM or less. Nevertheless, the inventive coenzyme-binding glucose dehydrogenase enables a more sensitive measurement of D-glucose when using potassium ferricyanide at a concentration as high as 2 to 500 mM, more preferably 30 to 100 mM. A preferred embodiment of the inventive measurement method, measurement reagent, measurement compound, biosensor and the like is characterized by the use of potassium ferricyanide in its relevant measurement system at a final concentration of 2 to 500 mM.
  • EXAMPLES
  • The present invention is further described in the following Examples, by which the invention is not restricted without departing from its scope. In the following Examples, the quantification of a coenzyme-binding glucose dehydrogenase was conducted as described above.
  • Example 1 Culture of Deposited Strain 97508
  • 100 ml of a culture medium (pH6.0) containing 1% glucose (WAKO PURE CHEMICAL), 2% defatted soybean (NIPPON SHOKUHAN), 0.5% of corn steep liquor (KYODO SHOJI) and 0.1% magnesium sulfate (Nacalai Tesque) was placed in a 500-ml culture flask, which was sterilized at 121° C. for 20 minutes, cooled, inoculated with a platinum loop of the deposited strain 97508, shaken at 30° C. for 88 hours to obtain a seed culture of the strain. 4 L of the culture medium having the composition similar to that described above but supplemented with an antifoam agent was added to a 5-L jar fermenter, which was sterilized at 121° C. for 30 minutes, cooled, inoculated with 40 ml of the seed culture described above, cultured at 28° C. for 31 hours with aerating and shaking to obtain a preliminary culture of the strain. Then, 160 L of the culture medium having the composition similar to that described above but supplemented with an antifoam agent was added to a 200-L jar fermenter, which was sterilized at 121° C. for 20 minutes, cooled, inoculated with 1.6 L of the preliminary culture described above, cultured at 28° C. for 41 hours with aerating and shaking. After completion of the culture, the culture fluid was centrifuged to obtain the supernatant.
  • Example 2 Isolation of Coenzyme-Binding Glucose Dehydrogenase from the Culture Supernatant
  • By the following Steps 2.1 to 2.5, the coenzyme-binding glucose dehydrogenase was isolated.
  • 2.1 Concentration
  • 160 L of the culture supernatant of Example 1 was concentrated through an ultrafiltration membrane “Pellicon 2 Module” (Millipore), and transferred into a 20 mM potassium phosphate buffer (pH7.5) to obtain a crude enzyme solution.
  • 2.2 Purification by Butyl-TOYOPEARL 650M (TOSOH) (First Process)
  • The abovementioned crude enzyme solution was prepared in 65%-saturated ammonium sulfate (pH7.5), and centrifuged to obtain a supernatant. This treated crude enzyme solution was loaded onto a Butyl-TOYOPEARL 650M column (diameter: 4.7 cm, height: 7.7 cm) which had previously been equilibrated with a 20 mM potassium phosphate buffer (pH7.5) containing 65% ammonium sulfate; and thereby allowing the enzyme is absorbed therein. This column was washed with the same buffer solution, and then the enzyme was allowed to be eluted with 20 mM potassium phosphate buffer (pH7.5) containing 30% ammonium sulfate to collect an active fraction. The enzyme was further eluted by a gradient elution starting from the same buffer to 20 mM potassium phosphate buffer (pH7.5), and pooled with the former active fraction.
  • 2.3. Purification by DEAE-CELLULOFINE A-500 (SEIKAGAKU KOGYO)
  • The abovementioned active fraction was concentrated through an ultrafiltration membrane “Pellicon 2 Module”, desalted, and equilibrated with a 15 mM Tris-HCl buffer (pH8.5). This fraction was loaded onto a DEAE-CELLULOFINE A-500 column (diameter: 4.7 cm, height: 5.2 cm) which had previously been equilibrated with the same buffer solution, and the eluate was collected.
  • 2.4 Purification by Butyl-TOYOPEARL 650M (TOSOH) (Second Process)
  • The abovementioned eluate was prepared in 65%-saturated ammonium sulfate (pH7.5), and centrifuged to obtain a supernatant. This supernatant was loaded onto a Butyl-TOYOPEARL 650M column (diameter: 4.7 cm, height: 3.6 cm) which had previously been equilibrated with a 20 mM potassium phosphate buffer (pH7.5) containing 65% ammonium sulfate; thereby allowing the enzyme is absorbed. This column was washed with the same buffer solution, and then the enzyme was allowed to be eluted with 20 mM potassium phosphate buffer (pH7.5) containing 30% ammonium sulfate to collect an active fraction.
  • 2.5 Purification by TSKgel G3000SW (TOSOH)
  • The abovementioned active fraction was concentrated through a pencil type membrane concentration module “ACP-0013” (ASAHI KASEI), desalted, and equilibrated with 50 mM potassium phosphate buffer (pH5.5) containing 0.2M sodium chloride. This fraction was loaded onto a TSKgel G3000SW (diameter: 2.15 cm, height: 60 cm) which had previously been equilibrated with the buffer described above, and the enzyme was eluted with the same buffer to obtain an active fraction. The active fraction was concentrated through a centriplus 10 (Amicon), desalted, and transferred into a 50 mM citric acid-sodium phosphate buffer (pH5.5). The resultant enzyme approximately had a specific activity of 1,100 unit/mg, and a purification degree of about 170 times greater than that of the crude enzyme solution.
  • Example 3 Test of Characteristics of Coenzyme-Binding Glucose Dehydrogenase
  • The coenzyme-binding glucose dehydrogenase isolated in Example 2 described above was examined for its effect, optimum pH, pH for stability, optimum temperature, thermal stability, substrate specificity, molecular weight, inhibitor and coenzyme.
  • 3.1 Effect
  • The coenzyme-binding glucose dehydrogenase was reacted with 500 mM D-glucose in the presence of 8.66 mM DCIP, and the reaction product was quantified using D-gluconic acid/D-glucono-δ-lactone measurement kit. As a result, the production of D-gluconic acid was identified, and it was revealed that the inventive coenzyme-binding glucose dehydrogenase is the enzyme that catalyzes a reaction for oxidizing a hydroxyl group in the 1-position of D-glucose.
  • 3.2 Optimum pH
  • The buffer solution according to the Enzymatic activity measurement method 2 was replaced with the citric acid-sodium phosphate buffer (pH4.0 to 5.5), potassium phosphate buffer (pH6.5 to 7.5), Tris-HCl buffer (pH8.0 to 9.0) or glycine-sodium hydroxide buffer (pH9.5 to 10.0) (each 17 mM as a final concentration), and the enzymatic activity of the purified enzyme was measured at various pH ranges similarly to Enzymatic activity measurement method 2 (FIG. 1). As a result, the optimum pH of the coenzyme-binding glucose dehydrogenase was 7.0 to 9.0.
  • 3.3 pH for stability
  • The coenzyme-binding glucose dehydrogenase was dissolved in each 50 mM buffer, i.e., citric acid-sodium phosphate buffer (pH3.2 to 6.4), potassium phosphate buffer (pH6.3 to 6.9), Tris-HCl buffer (pH7.3 to 8.6) or glycine-sodium hydroxide buffer (pH9.1 to 11.4) and kept at 40° C. for 60 minutes, and then the enzymatic activity was examined by the method according to the activity measurement method 1, and a ratio of residual enzymatic activity was analyzed (FIG. 2). As a result, the pH for the stability of the coenzyme-binding glucose dehydrogenase was pH4.5 to 8.5.
  • 3.4 Optimum Temperature
  • The coenzyme-binding glucose dehydrogenase was dissolved in 50 mM citric acid-sodium phosphate buffer (pH5.5) and examined for the enzymatic activity over the range from 30° C. to 62° C. by the Enzymatic activity measurement method 1 described above (FIG. 3). As a result, the optimum temperature of the coenzyme-binding glucose dehydrogenase was about 55° C.
  • 3.5 Thermal Stability
  • The coenzyme-binding glucose dehydrogenase was dissolved in 50 mM citric acid-sodium phosphate buffer (pH5.5), kept at several points of the temperature ranging from 0° C. to 55° C. for 15 minutes, and then examined for the enzymatic activity by the Enzymatic activity measurement method 1, and the ratio (%) of residual enzymatic activity was analyzed (FIG. 4). The ratio (%) of residual enzymatic activity was calculated with regarding the enzymatic activity after keeping at 0° C. for 15 minutes as 100%. As a result, the coenzyme-binding glucose dehydrogenase kept its enzymatic activity at a level as high as 89% even at 50° C., showing the stability at about 50° C. or below.
  • 3.6 Substrate Specificity and Km Value
  • Employing each of D-glucose and other substrates (each at 333 mM as a final concentration, except for D-cellobiose at 193 mM, D-trehalose and D-raffinose at 121 mM), the enzymatic activity of this enzyme was measured by the Enzymatic activity measurement method 1. The activity on each substrate is represented as a relative value to the activity of this enzyme on D-glucose being regarded as 100%, and shown in Table 1.
  • Similarly, the relative reactivities (enzymatic activity) on D-glucose and maltose each at two final concentrations, i.e. 550 mM and 100 mM, were measured. The results are represented as relative values based on the value on D-glucose.
  • As evident from these results, the coenzyme-binding glucose dehydrogenase acts potently on D-glucose, and weakly on D-mannose, 1,5-anhydro-D-glucitol, D-cellobiose, D-trehalose, maltose, D-galactose, D-glucose-6-phosphate and D-fructose. This enzyme exhibited almost no effect on L-arabinose, lactose, D-sorbitol, gluconic acid, sucrose, D-mannitol, L-sorbose, D-ribose, L-rhamnose, D-glucose-1-phosphate, D-raffinose, ethanol or glycerol. The Km value of this enzyme was 49.7 mM on D-glucose.
  • TABLE 1
    Substrate Relative activity (%)
    D-Glucose 100
    2-Deoxy-D-glucose 48
    D-Xylose 9.1
    D-Mannose 2.8
    1,5-Anhydro-D-glucitol 2
    D-Cellobiose 2
    D-Trehalose 1.7
    Maltose 1.4
    D-Galactose 1.2
    D-Glucose-6-phosphate 1.1
    D-Fructose 0.86
    L-Arabinose 0.1>
    Lactose 0.1>
    D-Sorbitol 0.1>
    Gluconic acid 0.1>
    Sucrose 0.1>
    D-Mannitol 0.1>
    L-Sorbose 0.1>
    D-Ribose 0.1>
    L-Rhamnose 0.1>
    D-Glucose-1-phosphate 0.1>
    D-Raffinose 0.1>
    Ethanol 0.1>
    Glycerol 0.1>
  • TABLE 2
    Substrate Final Conc.(mM) Relative activity (%)
    D-Glucose 550 100
    Maltose 550 2.8
    D-Glucose 100 100
    Maltose 100 0.5
  • 3.7 Molecular Weight and Subunit Molecular Weight
  • The coenzyme-binding glucose dehydrogenase was dissolved in a 50 mM potassium phosphate buffer (pH7.5) containing 0.2M NaCl, and analyzed on a TSKgel-G3000SW (diameter: 0.75 cm, length: 60 cm, TOSOH) using the same buffer solution as a mobile phase. When using a molecular weight marker (Oriental Yeast) as an index, the molecular weight of the coenzyme-binding glucose dehydrogenase was revealed to be about 130 kDa. Using a 12.5% polyacrylamide gel, the inventive coenzyme-binding glucose dehydrogenase was subjected to an SDS-polyacrylamide gel electrophoresis (SDS-PAGE) according to the method by Laemmli et al (Nature, (1970) 227:680-685). After the running, the gel was stained with Coomassie brilliant blue, and the mobility was compared with that of the molecular weight marker (Amersham Pharmacia Biotech), which revealed that the subunit molecular weight of the inventive coenzyme-binding glucose dehydrogenase was about 85 kDa.
  • 3.8 Inhibitor
  • Each of the various additives shown in Table 3 was added as an inhibitor at 1 mM as a final concentration to the reaction system of the Enzymatic activity measurement method 1, and the activity of the coenzyme-binding glucose dehydrogenase was measured by the Enzymatic activity measurement method 1. In a control group, the procedure similar to that of Enzymatic activity measurement method 1 was conducted except for adding no additives shown in Table 3. Based on the enzymatic activity observed in the control group being regarded as 100%, the activity in the presence of each additive was calculated as a relative activity, the difference of which from the control group activity was regarded as a % inhibitory effect. As a result, the inhibitory effect shown in Table 3 was observed.
  • On the other hand, in the Enzymatic activity measurement method 1 described above, 1,10-phenanthroline respectively dissolved in methanol at 1 mM, 5 mM, 10 mM, 25 mM and 50 mM as final concentrations was added, and the activity of the inventive coenzyme-binding glucose dehydrogenase was measured in accordance with the Enzymatic activity measurement method 1. The final concentration of methanol relative to each reaction system was 10% (v/v). In a control group, methanol was added in the Enzymatic activity measurement method 1 at 10% (v/v) as a final concentration. The results are shown in Table 4. It was revealed that the inhibitory effect of 1,10-phenanthroline was as high as 62.0% at 1 mM, 76% at 5 mM, 85% at 10 mM, 91% at 25 mM and 95% at 50 mM as final concentrations of 1,10-phenanthroline.
  • The inhibitory effect on the inventive coenzyme-binding glucose dehydrogenase varied depending on the type of the additive, and was the highest in the presence of heavy metal ion (such as Ag+, Cu2+ and Hg2+), and was 60% or more in the presence of 1,10-phenanthroline, proflavin and Mn2+.
  • TABLE 3
    Additive Inhibition (%)
    None 0
    NaN 3 0
    ZnCl 2 0
    AlCl 3 0
    Benzoic acid 0
    EDTA 0.4
    CdCl2 0.8
    LiCl 0.9
    Aminoguanidine sulfate 1.1
    H2O2 1.7
    N-Ethylmaleimide 1.8
    Urea 1.9
    NaCl 2.5
    Tirone 2.5
    BaCl2 2.6
    PbCl2 2.7
    MgCl2 2.8
    Fumaric acid 3.4
    Cycloserine 3.6
    DL-Penicillamine 4.3
    Meso-tartaric acid 5.6
    Citric acid 5.6
    CaCl2 5.7
    Quinacrine 5.0
    TritonX-100 6.2
    CoCl2 7.0
    Malic acid 8.1
    D-Tartaric acid 8.5
    Iodoacetic acid 9.5
    Cysteamine 9.8
    2,2′-Bipyridine 10.8
    8-Quinolinol 13.9
    KCN 14.5
    NiCl2 16.5
    FeCl3 25.0
    Maleic acid 26.2
    Acrinol 29.0
    2-Nitrobenzoic acid 44.3
    SnCl2 45.5
    Acriflavine 49.0
    1,10-Phenanthroline 62.0
    Proflavin 62.0
    MnCl2 75.5
    AgNO3 99.4
    CuCl 2 100
    HgCl 2 100
  • TABLE 4
    Final concentration of
    1,10-phenanthroline (mM) Inhibit (%)
    0 0
    50 95
    25 91
    10 85
    5 76
  • 3.9. Coenzyme
  • The inventive coenzyme-binding glucose dehydrogenase solution was supplemented with D-glucose and subjected to the absorption analysis, which indicated the disappearance of the maximum absorptions observed at 385 nm and 465 nm in response to the supplement, revealing that the coenzyme was flavin adenine dinucleotide. These maximum absorptions are specific to FAD, and it was not observed in a control group reaction system constructed by excluding FAD only.
  • Example 4 Glucose Quantification
  • The coenzyme-binding glucose dehydrogenase derived from the deposited strain 97508 purified in Example 2 described above was employed, and the absorption reduction rate was measured using D-glucose at the concentration ranging from 0.333 to 33 mM instead of 333 mM D-glucose in the Enzymatic activity measurement method 1. Thus, the transition in the absorption was measured at each D-glucose concentration of 0.333 mM, 0.5 mM, 1 mM, 2 mM, 5 mM, 6.67 mM, 10 mM, 20 mM and 33 mM. The results of the measurement are shown in FIG. 5.
  • As a result, a calibration curve (correlation coefficient r=0.997) was obtained; thereby, it was apparent that the quantification of D-glucose employing the coenzyme-binding glucose dehydrogenase is possible.
  • Example 5 Measurement of Glucose by Enzyme-Immobilizing Electrode
  • The coenzyme-binding glucose dehydrogenase derived from the deposited strain 97508 purified in Example 2 described above was employed to measure D-glucose by an enzyme-immobilizing electrode. A glassy carbon (GC) electrode on which 3.4 U of this enzyme was immobilized was employed to measure the response current to the glucose concentration. In an electrolytic cell, 2.7 ml of 100 mM sodium phosphate buffer (pH7.0) and 0.3 ml of 1M aqueous solution of potassium hexacyanoferrate (III) (potassium ferricyanide) were added. The GC electrode was connected to the potentiostat BAS100B/W (BAS), and the solution was stirred at 40° C. in each condition of argon saturation, oxygen saturation and air saturation while applying +500 mV to the silver-silver chloride reference electrode. 30 μl of a 1M D-glucose solution was added to these systems, and the current value in the stationary phase was measured. The same amount of the 1M D-glucose solution was further added, and the current value was measured, these procedure being repeated each three times. The resultant current values vs the known glucose concentrations (about 10, 20, 30 and 40 mM) were plotted to obtain a calibration curve (FIG. 6). Thereby, it was apparent that the quantification of glucose by the enzyme-immobilizing electrode employing the coenzyme-binding glucose dehydrogenase is possible. It was also revealed, based on the consistent calibration curve obtained regardless of any gas saturated conditions, that the coenzyme-binding glucose dehydrogenase is extremely inert to the oxygen and that it is possible to quantify D-glucose by the enzyme-immobilizing electrode utilizing the enzyme without being subjected to any effect of the oxygen.
  • Example 6 Measurement of Glucose in Standard Serum by Enzyme-Immobilizing Electrode
  • Analogous to Example 5, the concentration of glucose in a serum was measured by the enzyme-immobilizing electrode using the control serum I WAKO B (WAKO PURE CHEMICAL). In an electrolytic cell, 2.4 ml of 100 mM sodium phosphate buffer (pH7.0) and 0.3 ml of 1M aqueous solution of potassium hexacyanoferrate (III) (potassium ferricyanide) were added, and the serum was added when the current value became stationary and the current value was measured. Similarly, the D-glucose solutions of known concentrations were measured to obtain a calibration curve. The glucose concentration in the serum was identified by the calibration curve method to be 4.5 mM, which was in agreement with the concentration of the glucose identified by the hexokinase-glucose-6-phosphate dehydrogenase method. Accordingly, it was revealed that the quantification of D-glucose in serum by the enzyme-immobilizing electrode employing the coenzyme-binding glucose dehydrogenase employed in the invention is possible.
  • INDUSTRIAL APPLICABILITY
  • According to the present invention, it became possible to provide a soluble coenzyme-binding glucose dehydrogenase whose activity on altose is 5% or less and which is inhibited by 1,10-phenanthroline. Furthermore, a method for producing the coenzyme-binding glucose dehydrogenase suitable to an industrial production and a microorganism producing therefor are also provided. As a result, it becomes possible to apply the coenzyme-binding glucose dehydrogenase to an industrial application, and more particularly, it becomes possible to measure the blood sugar level even in a diabetes patient receiving an infusion containing maltose. Also by using the inventive coenzyme-binding glucose dehydrogenase, a trace amount of the glucose can be measured even with a glucose sensor, thus enabling the utility. It also becomes possible to use in a material production or analysis including a method for measuring or eliminating glucose in a sample using the coenzyme-binding glucose dehydrogenase as well as a method for producing an organic compound, thereby providing a highly utilizable enzyme, which enables use for modifying a material in the fields of pharmaceuticals, clinical studies and food products.

Claims (2)

1-21. (canceled)
22. A biosensor for measuring glucose, comprising soluble flavin compound-binding glucose dehydrogenase, which:
(a) catalyzes a reaction for oxidizing glucose in the presence of an electron acceptor; and
(b) has a 5% or less specific activity to maltose relative to the enzymatic activity to glucose.
US12/851,668 2002-12-24 2010-08-06 Coenzyme-binding glucose dehydrogenase Abandoned US20100297743A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US12/851,668 US20100297743A1 (en) 2002-12-24 2010-08-06 Coenzyme-binding glucose dehydrogenase
US16/278,025 US11345897B2 (en) 2002-12-24 2019-02-15 Coenzyme-binding glucose dehydrogenase
US16/278,008 US10988738B2 (en) 2002-12-24 2019-02-15 Coenzyme-binding glucose dehydrogenase
US16/278,019 US11225645B2 (en) 2002-12-24 2019-02-15 Coenzyme-binding glucose dehydrogenase
US16/278,030 US11155789B2 (en) 2002-12-24 2019-02-15 Coenzyme-binding glucose dehydrogenase

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP2002373297 2002-12-24
JP2002-373297 2002-12-24
PCT/JP2003/016603 WO2004058958A1 (en) 2002-12-24 2003-12-24 Coenzyme-binding glucose dehydrogenase
US10/540,025 US7514250B2 (en) 2002-12-24 2003-12-24 Coenzyme-binding glucose dehydrogenase
US12/396,724 US20090176262A1 (en) 2002-12-24 2009-03-03 Coenzyme-binding glucose dehydrogenase
US12/851,668 US20100297743A1 (en) 2002-12-24 2010-08-06 Coenzyme-binding glucose dehydrogenase

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US12/396,724 Continuation US20090176262A1 (en) 2002-12-24 2009-03-03 Coenzyme-binding glucose dehydrogenase

Related Child Applications (4)

Application Number Title Priority Date Filing Date
US16/278,008 Continuation US10988738B2 (en) 2002-12-24 2019-02-15 Coenzyme-binding glucose dehydrogenase
US16/278,025 Continuation US11345897B2 (en) 2002-12-24 2019-02-15 Coenzyme-binding glucose dehydrogenase
US16/278,019 Continuation US11225645B2 (en) 2002-12-24 2019-02-15 Coenzyme-binding glucose dehydrogenase
US16/278,030 Continuation US11155789B2 (en) 2002-12-24 2019-02-15 Coenzyme-binding glucose dehydrogenase

Publications (1)

Publication Number Publication Date
US20100297743A1 true US20100297743A1 (en) 2010-11-25

Family

ID=32677255

Family Applications (7)

Application Number Title Priority Date Filing Date
US10/540,025 Active 2024-12-19 US7514250B2 (en) 2002-12-24 2003-12-24 Coenzyme-binding glucose dehydrogenase
US12/396,724 Abandoned US20090176262A1 (en) 2002-12-24 2009-03-03 Coenzyme-binding glucose dehydrogenase
US12/851,668 Abandoned US20100297743A1 (en) 2002-12-24 2010-08-06 Coenzyme-binding glucose dehydrogenase
US16/278,025 Active 2024-05-03 US11345897B2 (en) 2002-12-24 2019-02-15 Coenzyme-binding glucose dehydrogenase
US16/278,019 Expired - Lifetime US11225645B2 (en) 2002-12-24 2019-02-15 Coenzyme-binding glucose dehydrogenase
US16/278,030 Active 2024-04-10 US11155789B2 (en) 2002-12-24 2019-02-15 Coenzyme-binding glucose dehydrogenase
US16/278,008 Active 2024-03-19 US10988738B2 (en) 2002-12-24 2019-02-15 Coenzyme-binding glucose dehydrogenase

Family Applications Before (2)

Application Number Title Priority Date Filing Date
US10/540,025 Active 2024-12-19 US7514250B2 (en) 2002-12-24 2003-12-24 Coenzyme-binding glucose dehydrogenase
US12/396,724 Abandoned US20090176262A1 (en) 2002-12-24 2009-03-03 Coenzyme-binding glucose dehydrogenase

Family Applications After (4)

Application Number Title Priority Date Filing Date
US16/278,025 Active 2024-05-03 US11345897B2 (en) 2002-12-24 2019-02-15 Coenzyme-binding glucose dehydrogenase
US16/278,019 Expired - Lifetime US11225645B2 (en) 2002-12-24 2019-02-15 Coenzyme-binding glucose dehydrogenase
US16/278,030 Active 2024-04-10 US11155789B2 (en) 2002-12-24 2019-02-15 Coenzyme-binding glucose dehydrogenase
US16/278,008 Active 2024-03-19 US10988738B2 (en) 2002-12-24 2019-02-15 Coenzyme-binding glucose dehydrogenase

Country Status (8)

Country Link
US (7) US7514250B2 (en)
EP (1) EP1584675B1 (en)
JP (1) JP4494978B2 (en)
CN (1) CN100415877C (en)
AU (1) AU2003296186A1 (en)
CA (1) CA2511656A1 (en)
DE (1) DE60331477D1 (en)
WO (1) WO2004058958A1 (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110136158A1 (en) * 2009-04-30 2011-06-09 Takenaka Ryo Protein electron mediator
US8945359B2 (en) 2011-08-26 2015-02-03 Ikeda Food Research Co., Ltd. Flavin-binding glucose dehydrogenase
US8999691B2 (en) 2010-06-29 2015-04-07 Ultizyme International Ltd. Glucose dehydrogenase
US9074239B2 (en) 2011-06-07 2015-07-07 Kikkoman Corporation Flavin-binding glucose dehydrogenase, method for producing flavin-binding glucose dehydrogenase, and glucose measurement method
US9238802B2 (en) 2010-12-01 2016-01-19 Kikkoman Corporation E. coli transformant, method for producing flavin-bound glucose dehydrogenase using the same, and mutant flavin-bound glucose dehydrogenases
US9260699B2 (en) 2011-10-31 2016-02-16 Toyobo Co., Ltd. Glucose dehydrogenase
US9404144B2 (en) 2012-02-09 2016-08-02 Toyobo Co., Ltd. Glucose dehydrogenase
US9469844B2 (en) 2010-12-02 2016-10-18 Kikkoman Corporation Flavin-bound glucose dehydrogenases, a method for producing a flavin-bound glucose dehydrogenase, and yeast transformant used for the same
US9493814B2 (en) 2011-11-02 2016-11-15 Kikkoman Corporation Flavin-binding glucose dehydrogenase having improved substrate specificity
US9506042B2 (en) 2012-06-29 2016-11-29 Toyobo Co., Ltd. Glucose dehydrogenase
US9512459B2 (en) 2011-12-28 2016-12-06 Ultizyme International Ltd. Glucose dehydrogenase
US9657325B2 (en) 2013-10-21 2017-05-23 Toyobo Co., Ltd. Glucose dehydrogenase
US9796963B2 (en) 2012-09-10 2017-10-24 Toyobo Co., Ltd. Glucose dehydrogenase
US10913971B2 (en) 2015-04-09 2021-02-09 Toyobo Co., Ltd. Enzyme preparation for use in measurement of glucose
US11072809B2 (en) 2015-01-16 2021-07-27 Toyobo Co., Ltd. FAD-dependent glucose dehydrogenase

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7514250B2 (en) 2002-12-24 2009-04-07 Ikeda Food Research Co., Ltd. Coenzyme-binding glucose dehydrogenase
EP2380980B1 (en) * 2005-03-25 2014-11-05 Ikeda Food Research Co. Ltd. Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same
JP4746926B2 (en) * 2005-06-29 2011-08-10 シスメックス株式会社 Glucose-6-phosphate dehydrogenase-containing reagent and glucose-6-phosphate dehydrogenase stabilization method
TW200718786A (en) * 2005-11-07 2007-05-16 Toyo Boseki Lovel kglucose dehydrogenase
US20070105174A1 (en) * 2005-11-07 2007-05-10 Toyo Boseki Kabushiki Kaisha Novel glucose dehydrogenase
TW200718785A (en) 2005-11-10 2007-05-16 Toyo Boseki A process for improving the thermal stability of a composition containing a soluble coenzyme conjugated glucose dehydrogenase (GDH)
US7553649B2 (en) 2006-03-31 2009-06-30 Toyo Boseki Kabushiki Kaisha Method for producing glucose dehydrogenase from Aspergillus oryzae
JP2008154573A (en) * 2006-03-31 2008-07-10 Toyobo Co Ltd Method for enhancing stability of composition comprising soluble glucose dehydrogenase (gdh)
US7494794B2 (en) * 2006-03-31 2009-02-24 Toyo Boseki Kabushiki Kaisha Glucose dehydrogenase
US7741100B2 (en) * 2006-03-31 2010-06-22 Toyo Boseki Kabushiki Kaisha Method for highly expressing recombinant glucose dehydrogenase derived from filamentous fungi
US20080003628A1 (en) * 2006-03-31 2008-01-03 Toyo Boseki Kabushiki Kaisha Method for enhancing stability of a composition comprising soluble glucose dehydrogenase (gdh)
GB2449207B (en) * 2006-03-31 2009-05-20 Toyo Boseki Glucose dehydrogenase
JP2008154572A (en) * 2006-03-31 2008-07-10 Toyobo Co Ltd Method for producing filamentous fungus-derived glucose dehydrogenase
JP4179384B2 (en) * 2006-03-31 2008-11-12 東洋紡績株式会社 Process for producing glucose dehydrogenase from Aspergillus oryzae
US20080090278A1 (en) * 2006-03-31 2008-04-17 Toyo Boseki Kabushiki Kaisha Method for enhancing stability of a composition comprising soluble glucose dehydrogenase (gdh)
JP5489092B2 (en) * 2006-04-19 2014-05-14 パナソニックヘルスケア株式会社 Biosensor
CN101427128B (en) * 2006-04-19 2013-12-04 松下电器产业株式会社 Biosensor
CN103981157A (en) * 2006-05-29 2014-08-13 天野酶株式会社 Flavin adenine dinucleotide-binding glucose dehydrogenase
US8492130B2 (en) 2006-06-29 2013-07-23 Ikeda Food Research Co., Ltd. FAD-conjugated glucose dehydrogenase gene
DE602007012130D1 (en) * 2006-11-14 2011-03-03 Toyo Boseki MODIFIED FLAVIN-ADENINE-DINUCLEOTIDE-DEPENDENT GLUCOSE-DEHYDROGENASE
EP2083074B1 (en) 2006-11-14 2011-01-19 Toyo Boseki Kabushiki Kaisha Modified flavine-adenine-dinucleotide-dependent glucose dehydrogenase
WO2008102639A1 (en) * 2007-02-20 2008-08-28 Toyo Boseki Kabushiki Kaisha Method for electrochemical quantification of glucose, glucose dehydrogenase composition, and electrochemical sensor for determination of glucose
WO2009069381A1 (en) 2007-11-28 2009-06-04 Amano Enzyme Inc. Transformant transfected with flavin adenine dinucleotide-binding glucose dehydrogenase gene and method for producing flavin adenine dinucleotide-binding glucose dehydrogenase using the same
WO2009084616A1 (en) 2007-12-28 2009-07-09 Ikeda Food Research Co., Ltd. Modified glucose dehydrogenase gene
JP5380888B2 (en) * 2008-04-08 2014-01-08 東洋紡株式会社 Method for quantitative determination of glucose and quantitative composition
JP4770911B2 (en) * 2008-11-05 2011-09-14 東洋紡績株式会社 Method for improving the thermal stability of a composition comprising soluble coenzyme linked glucose dehydrogenase (GDH)
US8445246B2 (en) 2009-06-04 2013-05-21 Kikkoman Corporation Flavin-binding glucose dehydrogenases
WO2011004654A1 (en) * 2009-07-10 2011-01-13 天野エンザイム株式会社 Glucose dehydrogenase derived from mucor microorganism
WO2011034108A1 (en) 2009-09-16 2011-03-24 東洋紡績株式会社 Modified flavine-adenine-dinucleotide-dependent glucose dehydrogenase
CN103981158A (en) 2009-12-05 2014-08-13 天野酶株式会社 Mutant enzyme and application thereof
JP5899616B2 (en) * 2009-12-28 2016-04-06 東洋紡株式会社 A method to improve the temperature dependence of flavin adenine dinucleotide-dependent glucose dehydrogenase
WO2013022074A1 (en) 2011-08-11 2013-02-14 東洋紡株式会社 Novel glucose dehydrogenase
JP5896375B2 (en) 2011-09-09 2016-03-30 池田食研株式会社 Modified glucose dehydrogenase gene
JP5584740B2 (en) 2011-09-26 2014-09-03 アークレイ株式会社 Glucose sensor
JP2013081399A (en) * 2011-10-06 2013-05-09 Toyobo Co Ltd New glucose dehydrogenase
CA2876484A1 (en) 2012-06-15 2013-12-19 Microvi Biotech Inc. Novel biocatalyst compositions and processes for use
WO2015141761A1 (en) 2014-03-21 2015-09-24 池田食研株式会社 Flavin-binding glucose dehydrogenase
US11046935B2 (en) 2015-11-06 2021-06-29 Amano Enzyme Inc. Glucose dehydrogenase
US10961514B2 (en) 2016-01-14 2021-03-30 Ikeda Food Research Co., Ltd. Flavin-conjugated glucose dehydrogenase
WO2017195765A1 (en) 2016-05-09 2017-11-16 キッコーマン株式会社 Flavin-binding glucose dehydrogenase variant
WO2018062103A1 (en) * 2016-09-28 2018-04-05 天野エンザイム株式会社 Glucose dehydrogenase
JP6453385B2 (en) 2017-06-14 2019-01-16 池田食研株式会社 Modified glucose dehydrogenase
CN110607248B (en) * 2018-06-16 2021-01-01 华中农业大学 Fogerella strain A6 for repairing soil cadmium pollution and application
CN109596750A (en) * 2019-01-09 2019-04-09 新疆医科大学 A method of allinase is measured based on SEC-HPLC
CN110195030A (en) * 2019-05-10 2019-09-03 中国农业科学院饲料研究所 HIF1 α albumen is screening the application in the safe feeding additive of liver lipid lowering as biomarker
US20220322978A1 (en) 2019-09-30 2022-10-13 Phc Holdings Corporation High molecular weight redox polymer and biosensor using same
CN114085795B (en) * 2021-11-25 2023-07-07 浙江理工大学 Strain and process for improving humus soil of refuse landfill into greening planting soil

Citations (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2006001A (en) * 1934-09-10 1935-06-25 Standard Oil Co California Apparatus for annealing
US4767785A (en) * 1984-01-18 1988-08-30 Michael Georgieff Hypocaloric preparation and intravenous method for hypocaloric treatment of patients
US5120420A (en) * 1988-03-31 1992-06-09 Matsushita Electric Industrial Co., Ltd. Biosensor and a process for preparation thereof
US5286362A (en) * 1990-02-03 1994-02-15 Boehringer Mannheim Gmbh Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor
US5413690A (en) * 1993-07-23 1995-05-09 Boehringer Mannheim Corporation Potentiometric biosensor and the method of its use
US5762770A (en) * 1994-02-21 1998-06-09 Boehringer Mannheim Corporation Electrochemical biosensor test strip
US6071391A (en) * 1997-09-12 2000-06-06 Nok Corporation Enzyme electrode structure
US6103509A (en) * 1997-03-03 2000-08-15 Lifescan Inc. Modified glucose dehydrogenase
US6338790B1 (en) * 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US7005048B1 (en) * 1999-10-05 2006-02-28 Matsushita Electric Industrial Co., Ltd. Glucose sensor
US7049114B1 (en) * 1999-04-30 2006-05-23 Koji Sode Glucose dehydrogenase
US7132270B2 (en) * 2000-10-27 2006-11-07 Roche Diagnostics Gmbh Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase
US7276146B2 (en) * 2001-11-16 2007-10-02 Roche Diagnostics Operations, Inc. Electrodes, methods, apparatuses comprising micro-electrode arrays
US20080014612A1 (en) * 2006-03-31 2008-01-17 Toyo Boseki Kabushiki Kaisha Method for producing glucose dehydrogenase from aspergillus oryzae
US20080206833A1 (en) * 2005-06-20 2008-08-28 Arkray, Inc. Mutant Glucose Dehydrogenase
US20080248514A1 (en) * 2007-02-20 2008-10-09 Toyo Boseki Kabushiki Kaisha Electrochemical method for glucose quantification, glucose dehydrogenase composition, and electrochemical sensor for glucose measurement
US20100135977A1 (en) * 2006-10-12 2010-06-03 Krzysztof Palczewski Compositions and methods for treating metabolic diseases
US7741090B2 (en) * 2000-10-31 2010-06-22 Koji Sode Glucose dehydrogenase and process for producing the dehydrogenase

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0094161A1 (en) 1982-05-07 1983-11-16 Imperial Chemical Industries Plc Method for determining glucose content of fluid
US5364770A (en) * 1985-08-29 1994-11-15 Genencor International Inc. Heterologous polypeptides expressed in aspergillus
JPH0758272B2 (en) 1986-12-01 1995-06-21 松下電器産業株式会社 Glucose sensor
JPS63139243A (en) 1986-12-01 1988-06-11 Matsushita Electric Ind Co Ltd Glucose sensor
JPS63317757A (en) 1987-06-19 1988-12-26 Matsushita Electric Ind Co Ltd Glucose sensor
JPH04215055A (en) 1990-10-11 1992-08-05 Nok Corp Glucose biosensor
US5593852A (en) 1993-12-02 1997-01-14 Heller; Adam Subcutaneous glucose electrode
JP2959221B2 (en) 1991-08-21 1999-10-06 松下電器産業株式会社 Manufacturing method of glucose sensor
JP3084877B2 (en) 1992-01-21 2000-09-04 松下電器産業株式会社 Manufacturing method of glucose sensor
DE4301904A1 (en) 1992-08-07 1994-02-10 Boehringer Mannheim Gmbh Hypoglycosylated recombinant glucose oxidase
EP2295581A3 (en) * 1996-01-19 2011-05-04 Novozymes Biotech, Inc. Morphological mutants of filamentous fungi
US5879921A (en) 1996-11-07 1999-03-09 Novo Nordisk A/S Recombinant expression of a glucose oxidase from a cladosporium strain
JPH10239273A (en) 1997-02-26 1998-09-11 Akebono Brake Res & Dev Center Ltd Glucose sensor
US6059946A (en) * 1997-04-14 2000-05-09 Matsushita Electric Industrial Co., Ltd. Biosensor
US6656702B1 (en) * 1998-07-03 2003-12-02 Matsushita Electric Industrial Co., Ltd. Biosensor containing glucose dehydrogenase
JP3694424B2 (en) 1998-09-29 2005-09-14 松下電器産業株式会社 Glucose sensor
US6100037A (en) 1999-01-07 2000-08-08 Incyte Pharmaceuticals, Inc. Human cyclic nucleotide PDEs
JP2000262281A (en) 1999-03-18 2000-09-26 Koji Hayade Crosslinked glucose dehydrogenase
JP2000350588A (en) 1999-04-08 2000-12-19 Koji Hayade Glucose dehydrogenase
JP2001197888A (en) 2000-01-18 2001-07-24 Koji Hayade Glucose dehydrogenase having excellent substrate specificity
JP2000312588A (en) * 1999-04-30 2000-11-14 Koji Hayade Glucose dehydrogenase
JP4526638B2 (en) 1999-06-01 2010-08-18 月桂冠株式会社 High protein expression system
JP2001037483A (en) 1999-07-30 2001-02-13 Koji Hayade Linked glucose dehydrogenase
US6616819B1 (en) 1999-11-04 2003-09-09 Therasense, Inc. Small volume in vitro analyte sensor and methods
KR100445489B1 (en) 1999-11-15 2004-08-21 마츠시타 덴끼 산교 가부시키가이샤 Biosensor, method of forming thin-film electrode, and method and apparatus for quantitative determination
JP2000354495A (en) 2000-01-01 2000-12-26 Koji Hayade Production of glucose dehydrogenase
JP2001346587A (en) 2000-06-08 2001-12-18 Koji Hayade Glucose dehydrogenase excellent in substrate specificity
JP2002223772A (en) 2001-02-01 2002-08-13 Gekkeikan Sake Co Ltd Catalase a gene
CA2440576A1 (en) 2001-03-13 2002-09-19 Koji Sode Glucose dehydrogenase
DE60205702T2 (en) 2001-05-15 2006-02-02 Matsushita Electric Industrial Co., Ltd., Kadoma BIOSENSOR
US20030082595A1 (en) 2001-08-03 2003-05-01 Bo Jiang Nucleic acids of aspergillus fumigatus encoding industrial enzymes and methods of use
JP2004344145A (en) 2002-05-27 2004-12-09 Toyobo Co Ltd Pyrroloquinoline quinone (pqq) dependent modified glucosedehydrogenase substance excellent in substrate specificity and stability
CA2403025A1 (en) 2002-10-08 2004-04-08 Cognis Deutschland Gmbh & Co. Kg Enzymes with lipase/acyltransferase activity
JP2004173538A (en) 2002-11-25 2004-06-24 Amano Enzyme Inc Pyrroloquinolinequinone dependent glucose dehydrogenase
US7514250B2 (en) 2002-12-24 2009-04-07 Ikeda Food Research Co., Ltd. Coenzyme-binding glucose dehydrogenase
JP4332794B2 (en) 2003-03-24 2009-09-16 東洋紡績株式会社 Modified pyrroloquinoline quinone (PQQ) -dependent glucose dehydrogenase excellent in substrate specificity or stability
JP4029346B2 (en) 2003-03-24 2008-01-09 東洋紡績株式会社 Modified pyrroloquinoline quinone (PQQ) -dependent glucose dehydrogenase excellent in substrate specificity or stability
JP5105691B2 (en) 2003-05-09 2012-12-26 月桂冠株式会社 Cyclic nucleotide derived from Aspergillus filamentous fungi, method for producing Aspergillus filamentous fungus self-cloning strain, and self-cloning strain
AU2004288134B2 (en) 2003-08-11 2009-12-17 Codexis, Inc. Improved glucose dehydrogenase polypeptides and related polynucleotides
EP1666586B1 (en) 2003-09-08 2009-10-21 Toyo Boseki Kabushiki Kaisha Pyrroloquinoline quinone (pqq)-dependent glucose dehydrogenase modification having excellent substrate specificity
JP2005089884A (en) 2003-09-12 2005-04-07 Mitsubishi Rayon Co Ltd Method for producing carbon fiber precursor acrylic fiber bundle
WO2005088288A1 (en) 2004-03-10 2005-09-22 National Institute Of Advanced Industrial Science And Technology Carbon nanotube biosensor
JP4639302B2 (en) 2004-04-23 2011-02-23 アークレイ株式会社 Mutant glucose dehydrogenase
EP2380980B1 (en) 2005-03-25 2014-11-05 Ikeda Food Research Co. Ltd. Coenzyme-linked glucose dehydrogenase and polynucleotide encoding the same
GB2449207B (en) 2006-03-31 2009-05-20 Toyo Boseki Glucose dehydrogenase
JP2008154572A (en) 2006-03-31 2008-07-10 Toyobo Co Ltd Method for producing filamentous fungus-derived glucose dehydrogenase
US7741100B2 (en) 2006-03-31 2010-06-22 Toyo Boseki Kabushiki Kaisha Method for highly expressing recombinant glucose dehydrogenase derived from filamentous fungi
JP4179384B2 (en) 2006-03-31 2008-11-12 東洋紡績株式会社 Process for producing glucose dehydrogenase from Aspergillus oryzae
JP2007289148A (en) 2006-03-31 2007-11-08 Toyobo Co Ltd Method for producing glucose dehydrogenase derived from aspergillus oryzae
WO2007132461A2 (en) * 2006-05-11 2007-11-22 Ramot At Tel Aviv University Ltd. Classification of protein sequences and uses of classified proteins
CN103981157A (en) 2006-05-29 2014-08-13 天野酶株式会社 Flavin adenine dinucleotide-binding glucose dehydrogenase
US8492130B2 (en) 2006-06-29 2013-07-23 Ikeda Food Research Co., Ltd. FAD-conjugated glucose dehydrogenase gene
JP2008206433A (en) 2007-02-26 2008-09-11 Toyobo Co Ltd Dna encoding glucose dehydrogenase
WO2009084616A1 (en) 2007-12-28 2009-07-09 Ikeda Food Research Co., Ltd. Modified glucose dehydrogenase gene
CN102414319A (en) 2009-04-30 2012-04-11 池田食研株式会社 Protein-type electron mediator
JP6493212B2 (en) 2013-10-21 2019-04-03 東洋紡株式会社 Novel glucose dehydrogenase
US20170136102A1 (en) 2014-03-27 2017-05-18 Umender Kumar SHARMA Phage-derived compositions for improved mycobacterial therapy

Patent Citations (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2006001A (en) * 1934-09-10 1935-06-25 Standard Oil Co California Apparatus for annealing
US4767785A (en) * 1984-01-18 1988-08-30 Michael Georgieff Hypocaloric preparation and intravenous method for hypocaloric treatment of patients
US5120420A (en) * 1988-03-31 1992-06-09 Matsushita Electric Industrial Co., Ltd. Biosensor and a process for preparation thereof
US5120420B1 (en) * 1988-03-31 1999-11-09 Matsushita Electric Ind Co Ltd Biosensor and a process for preparation thereof
US5286362A (en) * 1990-02-03 1994-02-15 Boehringer Mannheim Gmbh Method and sensor electrode system for the electrochemical determination of an analyte or an oxidoreductase as well as the use of suitable compounds therefor
US5413690A (en) * 1993-07-23 1995-05-09 Boehringer Mannheim Corporation Potentiometric biosensor and the method of its use
US5762770A (en) * 1994-02-21 1998-06-09 Boehringer Mannheim Corporation Electrochemical biosensor test strip
US6103509A (en) * 1997-03-03 2000-08-15 Lifescan Inc. Modified glucose dehydrogenase
US6071391A (en) * 1997-09-12 2000-06-06 Nok Corporation Enzyme electrode structure
US6592745B1 (en) * 1998-10-08 2003-07-15 Therasense, Inc. Method of using a small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US6338790B1 (en) * 1998-10-08 2002-01-15 Therasense, Inc. Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator
US7049114B1 (en) * 1999-04-30 2006-05-23 Koji Sode Glucose dehydrogenase
US7005048B1 (en) * 1999-10-05 2006-02-28 Matsushita Electric Industrial Co., Ltd. Glucose sensor
US7132270B2 (en) * 2000-10-27 2006-11-07 Roche Diagnostics Gmbh Forms of soluble pyrroloquinoline quinone-dependent glucose dehydrogenase
US7741090B2 (en) * 2000-10-31 2010-06-22 Koji Sode Glucose dehydrogenase and process for producing the dehydrogenase
US7276146B2 (en) * 2001-11-16 2007-10-02 Roche Diagnostics Operations, Inc. Electrodes, methods, apparatuses comprising micro-electrode arrays
US20080206833A1 (en) * 2005-06-20 2008-08-28 Arkray, Inc. Mutant Glucose Dehydrogenase
US20080014612A1 (en) * 2006-03-31 2008-01-17 Toyo Boseki Kabushiki Kaisha Method for producing glucose dehydrogenase from aspergillus oryzae
US7655130B2 (en) * 2006-03-31 2010-02-02 Toyo Boseki Kabushiki Kaisha Glucose dehydrogenase from Aspergillus oryzae
US20100135977A1 (en) * 2006-10-12 2010-06-03 Krzysztof Palczewski Compositions and methods for treating metabolic diseases
US20080248514A1 (en) * 2007-02-20 2008-10-09 Toyo Boseki Kabushiki Kaisha Electrochemical method for glucose quantification, glucose dehydrogenase composition, and electrochemical sensor for glucose measurement

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Jin et al. (2008) Properties of glucoside 3-dehydrogenase and its potential applications, African J. Biotechnol., Vol.7, issue 25, pages 4843-4849. *
Kotera et al. (2004) Computational Assignment of the EC Numbers for Genomic-Scale Analysis of Enzymatic Reactions, J. Am. Chem. Soc., Vol.126, pages 16487-16498. *

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8969025B2 (en) 2009-04-30 2015-03-03 Panasonic Healthcare Holdings Co., Ltd. Protein electron mediator
US20110136158A1 (en) * 2009-04-30 2011-06-09 Takenaka Ryo Protein electron mediator
US8999691B2 (en) 2010-06-29 2015-04-07 Ultizyme International Ltd. Glucose dehydrogenase
US9238802B2 (en) 2010-12-01 2016-01-19 Kikkoman Corporation E. coli transformant, method for producing flavin-bound glucose dehydrogenase using the same, and mutant flavin-bound glucose dehydrogenases
US9469844B2 (en) 2010-12-02 2016-10-18 Kikkoman Corporation Flavin-bound glucose dehydrogenases, a method for producing a flavin-bound glucose dehydrogenase, and yeast transformant used for the same
US9074239B2 (en) 2011-06-07 2015-07-07 Kikkoman Corporation Flavin-binding glucose dehydrogenase, method for producing flavin-binding glucose dehydrogenase, and glucose measurement method
US8945359B2 (en) 2011-08-26 2015-02-03 Ikeda Food Research Co., Ltd. Flavin-binding glucose dehydrogenase
US9260699B2 (en) 2011-10-31 2016-02-16 Toyobo Co., Ltd. Glucose dehydrogenase
US9493814B2 (en) 2011-11-02 2016-11-15 Kikkoman Corporation Flavin-binding glucose dehydrogenase having improved substrate specificity
US9512459B2 (en) 2011-12-28 2016-12-06 Ultizyme International Ltd. Glucose dehydrogenase
US9404144B2 (en) 2012-02-09 2016-08-02 Toyobo Co., Ltd. Glucose dehydrogenase
US9506042B2 (en) 2012-06-29 2016-11-29 Toyobo Co., Ltd. Glucose dehydrogenase
US9796963B2 (en) 2012-09-10 2017-10-24 Toyobo Co., Ltd. Glucose dehydrogenase
US9657325B2 (en) 2013-10-21 2017-05-23 Toyobo Co., Ltd. Glucose dehydrogenase
US11072809B2 (en) 2015-01-16 2021-07-27 Toyobo Co., Ltd. FAD-dependent glucose dehydrogenase
US10913971B2 (en) 2015-04-09 2021-02-09 Toyobo Co., Ltd. Enzyme preparation for use in measurement of glucose

Also Published As

Publication number Publication date
US20060063217A1 (en) 2006-03-23
CN1726277A (en) 2006-01-25
US11225645B2 (en) 2022-01-18
US10988738B2 (en) 2021-04-27
US20190177701A1 (en) 2019-06-13
WO2004058958A1 (en) 2004-07-15
US20090176262A1 (en) 2009-07-09
JP4494978B2 (en) 2010-06-30
US7514250B2 (en) 2009-04-07
US20190177700A1 (en) 2019-06-13
EP1584675A1 (en) 2005-10-12
JPWO2004058958A1 (en) 2006-04-27
US20190177698A1 (en) 2019-06-13
CA2511656A1 (en) 2004-07-15
US20190177699A1 (en) 2019-06-13
CN100415877C (en) 2008-09-03
DE60331477D1 (en) 2010-04-08
AU2003296186A1 (en) 2004-07-22
EP1584675A4 (en) 2006-05-24
US11155789B2 (en) 2021-10-26
US11345897B2 (en) 2022-05-31
EP1584675B1 (en) 2010-02-24

Similar Documents

Publication Publication Date Title
US11225645B2 (en) Coenzyme-binding glucose dehydrogenase
Turner et al. Carbon monoxide: acceptor oxidoreductase from Pseudomonas thermocarboxydovorans strain C2 and its use in a carbon monoxide sensor
Hiner et al. A comparative study of the purity, enzyme activity, and inactivation by hydrogen peroxide of commercially available horseradish peroxidase isoenzymes A and C
Suylen et al. Methyl mercaptan oxidase, a key enzyme in the metabolism of methylated sulphur compounds by Hyphomicrobium EG
Mukund et al. The novel tungsten-iron-sulfur protein of the hyperthermophilic archaebacterium, Pyrococcus furiosus, is an aldehyde ferredoxin oxidoreductase. Evidence for its participation in a unique glycolytic pathway
Nazari et al. Peroxidative phenol removal from aqueous solutions using activated peroxidase biocatalyst
Prosser et al. Soil oxidoreductases and FDA hydrolysis
Ward et al. The NADH oxidase from Pyrococcus furiosus: implications for the protection of anaerobic hyperthermophiles against oxidative stress
STIRLING et al. Purification and properties of an NAD (P)+-linked formaldehyde dehydrogenase from Methylococcus capsulatus (Bath)
Eisbrenner et al. The number of hydrogenases in cyanobacteria
Sorokin et al. Aerobic carboxydotrophy under extremely haloalkaline conditions in Alkalispirillum/Alkalilimnicola strains isolated from soda lakes
Yang et al. Characterization of an exceedingly active NADH oxidase from the anaerobic hyperthermophilic bacterium Thermotoga maritima
Sadana et al. The purification and properties of cellobiose dehydrogenase from Sclerotium rolfsii and its role in cellulolysis
Fortin et al. A glutathione S-transferase catalyzes the dehalogenation of inhibitory metabolites of polychlorinated biphenyls
Shaeer et al. A highly stable manganese catalase from Geobacillus thermopakistaniensis: molecular cloning and characterization
Sun et al. Novel thermostable enzymes from Geobacillus thermoglucosidasius W-2 for high-efficient nitroalkane removal under aerobic and anaerobic conditions
US20130052679A1 (en) L-threonine analysis method and l-threonine dehydrogenase
Sibirny et al. Formaldehyde oxidizing enzymes and genetically modified yeast Hansenula polymorpha cells in monitoring and removal of formaldehyde
Yang et al. Purification and characterization of an NADH oxidase from extremely thermophilic anaerobic bacterium Thermotoga hypogea
Silver et al. Rhodanese from Thiobacillus A2: catalysis of reactions of thiosulphate with dihydrolipoate and dihydrolipoamide
Moon et al. Biochemical characterization of a thermostable cobalt-or copper-dependent polyphenol oxidase with dye decolorizing ability from Geobacillus sp. JS12
Ibrahim et al. Determination of mercury and nickel by amperometric biosensor prepared with thermostable lactate dehydrogenase
Gómez et al. Modelling of ferrous sulphate oxidation by Thiobacillus ferrooxidans in discontinuous culture: influence of temperature, pH and agitation rate
Boontim et al. Purification and characterization of D-glucose dehydrogenase from Bacillus thuringiensis M15
Yang Investigation of Flavoproteins Involved in the Metabolism of Anaerobic Hyperthermophilic Microorganisms

Legal Events

Date Code Title Description
STCV Information on status: appeal procedure

Free format text: APPLICATION INVOLVED IN COURT PROCEEDINGS

AS Assignment

Owner name: PHC CORPORATION, JAPAN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:IKEDA FOOD RESEARCH CO., LTD.;REEL/FRAME:045745/0779

Effective date: 20180419

STCV Information on status: appeal procedure

Free format text: COURT PROCEEDINGS TERMINATED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- AFTER EXAMINER'S ANSWER OR BOARD OF APPEALS DECISION